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Abstract 	  
Chapter 1. Catalytic olefin metathesis has developed into a powerful tool in the arsenal 
of the synthetic chemist as a quick and reliable method to build complexity in 
biologically active molecules. One particular subset of this class of reactions, catalytic 
olefin cross-metathesis, has seen great strides within the last decade. Using recently 
reported well-defined catalysts, chemists have been able to synthesize olefins in a 
stereoselective fashion via this reaction in a laboratory setting. While many classes of Z 
olefins have succumbed to this transformation, one class of olefins that has not been 
synthesized in a selective manner is that of Z-unsaturated esters, precious motifs found in 
a myriad of natural products. Traditional preparations of Z-acrylates and Z-dienoates are 
presented drawing examples from both total syntheses as well as method development 
reports.  
Chapter 2. A catalytic olefin cross-metathesis reaction utilizing E-dienoates as substrates 
is presented. A large variety of functionalized (E,Z)-dienoates are prepared in high yields 
and high stereoselectivities. This method has many advantages over more common 
methods of making these motifs, such as a wider substrate scope and the ability to be 
performed at ambient temperature.
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1. Traditional Preparation of Z-Acrylates and Z-Dienoates 
1.1 Introduction 
Olefins are some of the most widely used functional groups in organic synthesis. 
In many cases, alkenes are used as building blocks towards greater complexity and are 
key structures in some of the most prominent reactions in organic chemistry, such as 
catalytic cross couplings1 and dihydroxylation.2 Olefins are often utilized as valuable 
precursors to biologically active molecules, in both the cis and trans forms. However, in 
many cases, olefins are part of the final molecule as well, often with one isomeric form 
having significantly higher biological activity over the other.3 While nature has found 
means of generating olefins in a stereoselective fashion, chemists in the laboratory have 
found this challenge more difficult to overcome due to the fact that, in general, Z olefins 
are energetically higher than their corresponding E isomer. 
One area of stereoselective synthesis that has achieved great strides within the last 
decade is catalytic olefin metathesis.4 Through the rationalized design of catalysts,5 
chemists have been able to overcome the barrier to Z olefin formation for a large group of 
Z olefins in a stereoslective manner using various metathetic processes, including ring-
opening/cross-metathesis (ROCM),6 ring-closing metathesis (RCM),7 and cross-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Heck, R. F. Acc. Chem. Res. 1979, 12, 146−151. 
2 Sharpless, K. B. Angew. Chem. Int. Ed. 2002, 41, 2024−2032. 
3 Gaukroger, K.; Hadfield, J. A.; Hepworth, L. A.; Lawrence, N. J.; McGown, A. T. J. Org. Chem. 2001, 
66, 8135−8138. 
4	  For recent reviews on olefin metathesis see: (a) Schrock, R. R.; Hoveyda, A. H. Angew. Chem. Int. Ed. 
2003, 42, 4592−4633. (b) Samojlowicz, C.; Bieniek, M.; Grela, K. Chem. Rev. 2009, 109, 3708−3742. (c) 
Hoveyda, A. H.; Malcolmson, S. J.; Meek, S. J.; Zhugralin, A. R. Angew. Chem. Int. Ed. 2010, 49, 34−44. 
5 Sattely, E. S.; Meek, S. J.; Malcolmson, S. J.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 
131, 943−953.   
6 Ibrahem, I.; Yu, M.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3844−3845.   
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metathesis (CM).8 While significant progress has been made towards developing Z-
selective metathesis processes, there are still several challenges and classes of olefins that 
remain unsolved. 
One particular class of olefins that continues to be a challenge in olefin CM is Z-
α,β- and α,β,γ,δ-unsaturated esters. These olefins are found in a large variety of 
biologically active molecules (see Scheme 1.1 for representative examples),9 making 
methods that allow their generation in a stereoselective fashion important to further 
advance synthetic chemistry. While Z-selective RCM of these motifs has been very 
recently accomplished,10 Z-selective cross-metathesis of these architectures remains a 
challenge. In the first chapter of this thesis, traditional methods for the preparation of 
both Z-α,β- as well as (E,Z)- and (Z,E)-α,β,γ,δ-unsaturated ester olefins will be 
presented, drawing examples from both total syntheses and method development reports. 
The first chapter will then conclude with the most advanced metathesis reactions of these 
motifs. The second chapter of this work will describe our contribution to this field by 
using catalytic olefin cross-metathesis to generate these molecules in high 
stereoselectivity. 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 Wang, C.; Yu, M.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Chem. Eur. J. 
2013, 19, 2726−2740. 
8 Meek, S. J.; O’Brien, R. V.; Llaveria, J.; Schrock, R. R.; Hoveyda, A. H. Nature 2011, 471, 461−466. 
9 (a) Ghosh, A.K.; Shurrush, K. A.; Dawson, Z. L. Org. Biomol. Chem. 2013, 11, 7768−7777. (b) Pham, 
C.-D.; Hartmann, R.; Böhler, P.; Stork, B.; Wesselborg, S.; Lin, W.; Lai, D.; Proksch, P. Org. Lett. 2014, 
16, 266−269. (c) Smith, A. B.; Minbiole, K. P.; Verhoest, P. R.; Schelhaas, M. J. Am. Chem. Soc. 2001, 
123, 10942−10953. (d)  Enders, D.; Prokopenko, O. F. Liebigs Ann. 1995,  1185−1191. (e) Wang, L.-Y.; 
Wang, N.-L.; Yao X.-S.; Miyata, S.; Kitanaka, S. J. Nat. Prod. 2001, 65, 1246−1251. 
10 Zhang, H.; Yu, E. C.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 16493−
16496. 
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Scheme 1.1. Z-Unsaturated Esters in Biologically Active Natural Products
Me
 
 
 
 
 
 
 
 
 
 
1.2 Traditional Preparation of Z-Acrylates 
The majority of procedures to prepare Z-α,β-unsaturated ester olefins reported in 
the literature can be classified into two categories: (i) Those prepared via the Lindlar 
hydrogenation of an alkyne and (ii) Those prepared by the Still-Gennari modification of 
the Horner-Wadsworth-Emmons reaction. 
1.2.1 Preparation of Z-Acrylates via Lindlar Hydrogenation Alkynes 
As mentioned above, one of the notable methods for the preparation of Z-α,β-
unsaturated enoates is through the Lindlar hydrogenation of an alkyne. This method 
differs slightly from the more traditional palladium on carbon hydrogenation reaction in 
that this catalyst is palladium deposited on CaCO3 with a lead poison (often lead acetate). 
Along with this lead poison, the reaction is also often run with an additive, such as 
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Scheme 1.2. Use of Lindlar Hydrogenation in the Paterson Synthesis of (+)-Leucoscandrolide A
1.1 1.2
Me Me
quinoline, to prevent complete reduction down to the alkane from the alkyne.11 It is 
postulated that the Z selectivity is derived from the syn delivery of the two hydrogen 
atoms to the alkyne unit after splitting of the hydrogen molecule on the surface of the 
palladium catalyst.12  
One example of a Lindlar reduction in a total synthesis to generate a Z-acrylate 
was done by the Paterson group in their synthesis towards (+)-leucoscandrolide A 
(Scheme 1.2).13  After generating the di-alkyne intermediate 1.1, they subjected this 
macrocycle to H2 and Lindlar’s catalyst to obtain the Z-acrylate in exceptional yield and, 
as expected, all one isomer to complete the synthesis of the natural product (1.2). 
 
  
 
 
 
Another prominent example of this reaction being used in a synthesis setting was 
done by the Wender group during their campaign towards (−)-laulimalide, a potent anti-
cancer agent.14 Upon using the Yamaguchi Macrolactonization protocol15 to generate 
intermediate 1.3, they subjected this macrocycle to H2 and Lindlar’s catalyst to obtain 
intermediate 1.4 in 91% yield as one isomer at the acrylate olefin (Scheme 1.3). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11 Siau, W.-Y.; Zhang, Y.; Zhao, Y. Top. Curr. Chem. 2012, 327, 33−58. 
12 Mattson, B.; Foster, W.; Greimann, J.; Hoett, T.; Le, N.; Mirich, A.; Wankum, S.; Cabri, A.; 
Reichenbacher, C.; Schwanke, E. J. Chem. Educ. 2013, 90, 613−619. 
13 Paterson, I.; Tudge, M. Angew. Chem. Int. Ed. 2003, 42, 343−347. 
14 Wender, P. A.; Hedge, S. G.; Hubbard, R. D.; Zhang, L. J. Am. Chem. Soc. 2002, 124, 4956−4957. 
15 Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 
1989−1993.  
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Scheme 1.3. Use of Lindlar Hydrogenation in the Wender Synthesis of (−)-Laulimalide
O
OMOM O
OH
H O
OH
H
1.3
Pd(CaCO3)/Pb (2 x 5 mol %),
H2, quinoline,
1.4
91% yield
1:1 EtOAc:1-hexene, 22 °C, 4 h O
MOMO O
OH
OH
H
O
H
Following deprotection of the alcohol and Sharpless asymmetric epoxidation, the target 
compound was obtained in 3.5% yield with the longest linear sequence being 36 steps. 
This same synthetic sequence was also used by Ghosh in his synthesis of (−)-
laulimalide.16 After failing to obtain the target molecule through another route (which 
will be touched upon in the next section), he was able to obtain a similar intermediate as 
Wender in 94% yield, which was then carried through to the final target. 
 
 
 
 
  
While the Lindlar reduction appears to be a reliable method to obtain Z-acrylates 
in high stereoselectivity, there are certain problems associated with this method that must 
be addressed. The first problem associated with this reaction is the need to synthesize the 
alkyne moiety in the preceding intermediate to the Z olefin. Alkynes are not as readily 
available from commercial sources, requiring added steps in the overall synthesis to 
construct them and, in most cases, may need to be protected (due to their higher 
acidity/higher reactivity profile than alkenes), placing more time demands on the chemist. 
A second issue when using this method is the need to use toxic lead additives. As 
mentioned above, Lindlar’s catalyst is poisoned with a lead additive to tune down its 
reactivity. Lead is known to be toxic and requires more careful handling in order to 
prevent significant exposure. A third, and yet more significant problem, with the Lindlar 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
16 Ghosh, A. K.; Wang, Y.; Kim, J. T. J. Org. Chem. 2001, 66, 8973-8982.  
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reduction is that since the catalyst used in this reduction is a heterogenous catalyst, the 
quality of the catalyst may vary from batch to batch and may not give the same 
reproducibility from one batch to the next.11 Furthermore, the amount of catalyst used 
needs to be exactly right to reduce the alkyne to the alkene. If too little catalyst is used, 
the alkyne will not be fully consumed. If too much of the catalyst is used, then over 
reduction to the alkane is a significant possibility. This could be very detrimental to the 
synthesis as the alkane is often very difficult to oxidize back to the alkene and would 
require significantly more steps to obtain the desired alkene.11 
1.2.2 Preparation of Z-Acrylates Via the Still-Gennari Modification of    
the Horner-Wadsworth-Emmons Reaction  
 As mentioned above, the second strategy most commonly used to prepare Z-α,β-
unsaturated esters is through a modified version of the Horner-Wadsworth-Emmons 
(HWE) Reaction. The HWE reaction was developed as an easier way to prepare α,β-
unsaturated carbonyl olefins as an alternative to the widely used Wittig reaction. 
The use of phosphonate esters in the HWE reaction allows for easier purification 
of the product than the Wittig reaction. The phosphonate side chain generated is soluble 
in water and can be removed through an aqueous workup, whereas the phosphine oxide 
of the Wittig reaction cannot. Also, the HWE reaction provides a much broader scope.11 
However, this reaction usually provides the E product as the major stereoisomer. 
 In 1983, Still and Gennari introduced a modified HWE reaction in which they 
synthesized bis(trifluoroethyl) phosphonate esters from a trialkylphosphonate ester and 
trifluoroethanol and allowed them to react with aldehydes in the presence of a strong base 
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Scheme 1.4. Proposed Mechanism of the Still-Gennari Modification of the HWE Reaction
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O P
M-O
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to generate the corresponding Z olefin in high, to relatively high, Z selectivity.17 It is 
believed that the Z selectivity observed in these reactions is due to the addition of the 
deprotonated trifluoroalkyl phosphonate ester to the aldehyde favoring the anti mode of 
addition due to steric clash incurred in the syn mode of addition (Scheme 1.4). The 
resulting oxaphosphetane collapses quickly to give the desired Z alkene and prevent 
equilibration at the addition step.18  
 
 
 
 
 
 
 
 
 
 
The Still-Gennari modification of the HWE reaction has been applied in several 
total syntheses to make a Z-acrylate. One example of this strategy was shown by Forsyth 
and coworkers in their synthesis of phorboxazole A, an anticancer agent.19 After 
subjecting intermediate 1.5 (Scheme 1.5) to potassium carbonate and 18-crown-6, they 
were able to affect the intramolecular Still-Gennari olefination to generate intermediate 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
17 Still, W. C.; Gennari, C. Tetrahedron Lett. 1983, 24, 4405−4408. 
18 (a) Drawing recreated from: Strategic Applications of Named Reactions in Organic Synthesis (Kürti, L.; 
Czakó, B.), Elsevier Academic Press, Burlington, MA, 2005. (b) For additional material concerning the 
mechanism of the Still-Gennari reaction see: Maryanoff, B. E., Reitz, A. B. Chem. Rev. 1989, 89, 863−927. 
19 Forsyth, C. J.; Ahmed, F.; Cink, R. D., Lee, C. S. J. Am. Chem. Soc. 1998, 120, 5597−5598. 
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Scheme 1.5. Intramolecular Still-Gennari Reaction Performed in the Synthesis of Phorboxazole A
O
N
Boc O
O
O P (OR3)2
O
N
O
O
O
OTBDPS
O
1.5
K2CO3/ 18-Crown-6
toluene, −40 °C to −5 °C, 5h
O
N
Boc O
O
O
O
ON
O
OTBDPS
1.6
 4:1 Z:ER
3=CH2CF3
77% yield
1.6 in a 4:1 Z:E ratio and 77% yield. When the R3 group of intermediate 1.5 was just an 
ethyl group, they noted that the reaction gave roughly the same selectivity and yield. 
However, they observed that the reaction time was markedly faster using the 
trifluoroethyl phosphonate ester so the synthesis proceeded using the trifluoroethyl-
substituted ester. After this step, the target molecule was then accessed through further 
functional group manipulation and an amide coupling in a longest linear sequence of 34 
steps. 
 
 
 
 
 
 
Another example of this reaction being used to prepare Z-acrylates comes from 
the synthesis of (−)-laulimalide by Ghosh and coworkers.16 As mentioned above, the final 
strategy used to complete this synthesis was, in the end, a Lindlar reduction of an alkyne. 
Before they implemented this strategy, however, they attempted to make the acrylate 
moiety of the natural product through a Still-Gennari olefination. As shown in Scheme 
1.6, the best result the Ghosh group was able to obtain from the Still-Gennari reaction 
was a 1:1.5 cis:trans ratio of intermediate 1.8. They were able to separate the two isomers 
and attempted to isomerize the trans isomer. However, the lack of Z selectivity lead them 
to pursue the macrolactonization/Lindlar reduction strategy.  
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Scheme 1.6. Still-Gennari Olefination Employed in the Synthesis of (−)-Laulimalide
O
MOMO
O
OMOM
O
P O
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K2CO3/ 18-crown-6
toluene, −20 °C to −0 °C, 3h
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1.8b
O
MOMO
O
H
OMOM
O
O
 1:1.5 1.8b:1.8a
R2=CH2CF3
88% yield
Scheme 1.7. Still-Gennari Olefination Employed in the Synthesis of (−)-Laulimalide by the Trost group
O
OPMB
OMOMO
P
O
OCH2CF3
O
F3CH2CO
+
O
H
H
O
H H
O
OPMB
OMOMO
O
O
H
H
17:83 E:Z
KHMDS, 18-crown-6
thf, −78 °C, 25 min
1.9 1.10
1.11
50% yield of Z isomer
 
 
 
 
 
 
Following on from the Ghosh group’s synthesis of (−)-laulimalide, the Trost 
group attempted a total synthesis towards that natural product. They implemented a 
different strategy than Ghosh by attempting to make the Z-acrylate moiety first and 
closing the macrocycle at a later point in the synthesis (as opposed to closing the 
macrocycle through the Still-Gennari reaction as Ghosh did). Unfortunately they ran into 
the same problem as the Ghosh group encountered in that the best result they could 
obtain gave the desired alkene, 1.11 in an 83:17 Z:E ratio (Scheme 1.7).20 The isomers 
were separable from each other by column chromatography and so the synthesis was 
carried forward using the isolated Z isomer. 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
20 Trost, B. M.; Amans, D.; Seganish, W. M.; Chung, C. K. Chem. Eur. J. 2012, 18, 2961-2971. 
	   10	  
Scheme 1.8. Still-Gennari Olefination Employed in the Synthesis of Cholesterol Biosynthesis Inhibitor 1233A
P
O
CO2Me(F3CH2CO)2
KHMDS, 18-Crown-6
thf, toluene −78 °C to rt
12 h
OTHPO
CO2Me
OTHP
O
O
CO2Me
cholesterol biosynthesis inhibitor 1233A89% yield
1.12
1.13
 While all of the examples shown above have given less than desirable Z:E ratios 
in a synthesis setting, there are examples in the literature where the Still-Gennari 
olefination is a reliable reaction and gives high selectivity. For example the Ley group 
group found the reaction as an efficient way to give them the desired Z-acrylate in their 
synthesis of cholesterol biosynthesis inhibitor 1233A (Scheme 1.8).21 Intermediate 1.13 
was obtained in 89% yield after subjection of intermediate 1.12 to the standard Still-
Gennari reaction conditions. 1.13 was then used to set the stereochemistry of the oxetane 
dione stereogenic center in the target molecule in a later step. 
 
 
 
  
  
As the above examples show, there are significant drawbacks to using the Still-
Gennari olefination reaction for Z-acrylate synthesis. In a total synthesis setting it is 
highly desirable to have as stereoselective of a reaction as possible to prevent side 
products in future steps if separation of the two stereoisomers is not possible. While the 
Still-Gennari reaction does provide the desired Z isomer in relatively high selectivity in 
the cases shown above considering the molecular complexity involved, the reaction does 
not always provide one isomer exclusively and further purification may be needed to 
separate the stereoisomers. While in the above cases it was possible to separate the 
stereoisomers from each other, this will not always be the case.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
21  Bates, R. W.; Fernández-Megía, E.; Ley, S. V.; Rück-Braun, K.; Tilbrook, D. M. G. J. Chem. Soc., 
Perkin Trans. 1 1999, 1917-1925. 
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 Another significant drawback to the Still-Gennari olefination is the reagents 
needed for the reaction. In order for the reaction to occur, the metal of the base needs to 
be sequestered. In almost all cases this means adding a chelating agent such as 18-crown-
6. These reagents are toxic and precautions need to be taken before their use. Strong base 
is also required for the reaction, which mandates careful planning to avoid having base-
sensitive functionality in the starting material.  
 Along with all of the above-mentioned challenges with this reaction, the reaction 
also requires preparation of the phosphonate ester starting material, which adds more 
steps towards the target molecule if the reaction is being done in a total synthesis setting. 
Synthetic chemists generally desire the shortest synthesis possible. While it is easily 
prepared from simple starting materials, it is expensive in terms of time for the synthetic 
chemist to perform this reaction. 
 One last drawback to this method has to do with the waste generated. From an 
atom economy standpoint, it is not advantageous to install such a large amount of mass 
onto a molecule such as the phosphonate ester only to lose it one step later. Chemists 
desire to build complexity into their molecules instead of building complexity then 
removing it later on. 
 The two methods described above are the overwhelmingly favored methods in the 
literature for making 1,2-di-substituted acrylates in a cis fashion. While the two methods 
are stereoselective and offer different disconnections, they both have significant 
drawbacks that warrant consideration before their use. They are, however, currently the 
most utilized methods for the synthesis of Z-α,β-unsaturated esters. Further research 
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efforts should be aimed at designing reactions that mitigate these limitations and deliver 
the Z olefin in high stereoselectivity while offering different disconnections.  
 
1.3 Traditional Preparation of (E,Z)-and (Z,E)-Dienoates  
Dienoates and their derivatives are found in several naturally occurring 
biologically active molecules.22 As with the two strategies to construct Z-α,β-unsaturated 
esters (see part A), there are also two major strategies that the synthetic community has 
used to construct (E,Z)- and (Z,E)-α,β,γ,δ-unsaturated esters: the Still-Gennari reaction, 
and catalytic cross-coupling. While these reactions are the favorites, there are several 
other reactions that have been developed to generate these motifs that have not been 
examined to date in a synthesis setting. 
 
1.3.1 Generation of (Z,E)-Dienoates Through Still-Gennari Olefination 
One of the first examples of preparing the (2E,4Z)-dienoate architecture by Still-
Gennari olefination reported in the literature was in the campaign towards the antitumor 
agent, (+)-macbecin I by scientists at Merck Sharp and Dohme Research.23 As shown in 
Scheme 1.9, the group at Merck first prepared the Z-acrylate in intermediate 1.15 through 
this reaction. Following this and several functional group manipulations to aldehyde 1.16, 
the final (E,Z)-dienoate architecture of the natural product was furnished following a 
Wittig olefination to generate 1.17 in 83% yield over two steps. This same strategy 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
22 For representative examples of dienoates and dienoate derivatives in naturally occurring biologically 
active molecules, see: Wang, G.; Mohan, S.; Negishi, E. Proc. Nat. Acad. Sci. U.S.A 2011, 108, 11344−
11349 and Woerly, E. M.; Struble, J. R.; Palyam, N.; O’Hara, S. P.; Burke, M. D. Tetrahedron 2011, 67, 
4333−4343.  
23 Baker, R.; Castro, J. L. J. Chem. Soc. Perkin Trans. I 1990, 47−65. See also J. Chem. Soc., Chem. 
Comm. 1989, 378−381. 
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Scheme 1.9. Preparation of (2E,4Z)-Dienoate Via Sequential Still-Gennari/Wittig Olefination Reactions Towards (+)-Macbecin I
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O
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1.1599% isolated yield
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OMe
TBSOOMe
HO
H
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O
1.16
Ph3P OEt
O
CH2Cl2, 40 °C, 40h
OMe
OMe
OMe
OMe
TBSOOMeH
NF3C
O
OEtO1.1783% yield over 2 steps
towards the dienoate motif in (+)-macbecin was used by the Panek group. In their 
synthesis, the Z-acrylate was furnished by a Still-Gennari olefination with a final ratio of 
15:1 Z:E. The E olefin of the dienoate was then prepared via Wittig olefination.24  
 
 
 
 
 
 
 
Following the Merck synthesis of (+)-macbecin, the Evans group had identified 
this synthesis as one that could be improved upon with the latest developments in the 
field.25 In particular, they were interested in synthesizing the dienoate moiety in one step 
as opposed to the two shown in the Merck synthesis above. They rationalized that by 
using the sterically demanding, activated phosphonate ester that they could achieve 
kinetic selectivity and therefore generate the (E,Z)-dienoate in high stereoselectivity in 
one step. The best result from their model studies showed that they would only be able to 
achieve a 60% Z selectivity, nothing near what was desired. However, when they 
switched to the natural product system (Scheme 1.10) and increased the equivalents of 
the phosphonate ester (to 8 equivalents), they achieved a surprising selectivity of 73:27 
(E,Z):(E,E) obtained in 70% yield. With lower equivalents of the phosphonate ester they 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
24 Panek, J. S.; Xu, F. J. Am. Chem. Soc. 1995, 117, 10587−10588.  
25 Evans, D. A.; Miller, S. J.; Ennis, M. D. J. Org. Chem. 1993, 58, 471−485.  
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Scheme 1.10. Still-Gennari Olefination in the Evans Synthesis of (+)-Macbecin
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OMe
OMe TBSO
O OMe
1.18 1.19
73:27 Z:E
70% yield
were only able to achieve selectivity values near to what they observed from their model 
studies. 
 
 
 
 
Inspired by the work done by the Evans Group on (+)-macbecin, the Roush group 
decided to re-examine their previously published synthesis of (+)-damavirucin.26 The 
original route used to make that target involved a similar strategy described above by the 
Merck group en route to (+)-macbecin, involving making the Z olefin of the dienoate 
through a Still-Gennari olefination followed by an HWE olefination to make the E olefin. 
They attempted to improve the synthesis by cutting down the steps to the dienoate moiety 
as well as improving the Z selectivity, if possible. As shown in Scheme 1.11, as opposed 
to making the dienoate through sequential Still-Gennari followed by HWE olefination, 
they synthesized intermediate 1.22 as a 60% yield of a 4:1 mixture of the (E,Z):(E,E) 
isomers, which upon isolation of the Z isomer by preparative HPLC gave a final yield of 
47% for the Z isomer. In total, the route to the dienoate using the new sequence was 5 
steps and provided 1.22 in 30% overall yield. This new route negated the need to have 
three additional functional group manipulations and allowed the bypass of the non-trivial 
DIBAL reduction shown in the original route to 1.22 in Scheme 1.11.27 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
26  Roush, W. R.; Coffey, D. S.; Madar, D. J. J. Am. Chem. Soc. 1997, 119, 11331−11332. 
27  Chemler, S. R.; Coffey, D. S.; Roush, W. R. Tetrahedron Lett. 1999, 40, 1269−1272. 
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Scheme 1.11. Comparison Between Old Route and Improved Route to Install the Dienoate Motif of (+)-Damavaricin D
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While the previous examples used the Still-Gennari reaction to generate the olefin 
at the 4 position of the dienoate scaffold stereoselectively, there have been reports in the 
literature of using the same strategy to make the Z olefin at the 2 position. One such 
example comes from Curran’s synthesis of  (−)-dictyostatin, a known anticancer agent, to 
make the (2Z,4E)-dienoate.28 As shown in Scheme 1.12, following Dess-Martin 
periodinane oxidation of the alcohol in intermediate 1.23 to the aldehyde and subjecting 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
28 Shin, Y.; Fournier, J.-H.; Fukui, Y.; Brückner, A. M.; Curran, D. P. Angew. Chem. Int. Ed. 2004, 43,  
4634−4637. 
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Scheme 1.12. Still-Gennari Olefination Generating the Internal Z Olefin of the Dienoate Scaffold of (+)-Dictyostatin
OPMB
O
TBSO
TBSO OTBS OH
TBS
1) Dess-Martin Periodinane
 CH2Cl2, 22 °C, 1 h
86% yield over two steps
P OMe
OO
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thf, −78 °C, 4 h
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TBSO OTBS
TBS
CO2Me
1.23 1.24
2)
that intermediate to the deprotonated phosphonate ester under Still-Gennari conditions, 
Curran was able to isolate intermediate 1.24 with the (2Z,4E)-dienoate scaffold in 86% 
yield over the two steps. Further deprotection and cyclization would afford the target 
compound in 1% yield with a longest linear sequence of 34 steps. 
 
 
 
 
 
 
 Working on a less complex natural product, O’Doherty and coworkers were able 
to synthesize the (2Z,4E)-dienoate 1.26 from aldehyde 1.25 in high yield and 
exceptionally high stereoselectivity (Scheme 1.13).29 Two additional steps provided the 
natural product (−)-muricatacin, a potent cytotoxic compound in 66% yield and a 
synthesis of six steps. While the olefins are not preserved in the final product, the 
geometry of the olefin is essential to set the stereochemistry of the dihydroxylation in the 
next step. The O’Doherty group also carried out studies using the Still-Gennari 
olefination to synthesize a variety of (2Z,4E)-dienoates with very similar substrates as 
those in Scheme 1.13 and they were able to report a variety of these motifs in high 
stereoselectivity on their way to the synthesis of analogues for the antimicrobial natural 
product protoanemonin.30 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
29 Ahmed, M. M.; Cui, H. O’Doherty, G. A. J. Org. Chem. 2006, 71, 6686−6689.  
30 Ahmed, M. M.; Akhmedov, N. G.; Cui, H.; Friedrich, D.; O’Doherty, G. A. Heterocycles 2006, 70, 223−
233. 
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Scheme 1.13. Synthesis of the Dienoate Motif in (−)-Muricatacin
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1.3.2 Preparation of (E,Z)-Dienoates via Cross-Coupling Reactions 
Another powerful approach to the synthesis of conjugated dienoates is metal-
catalyzed cross-coupling. Suzuki, Negishi, and Heck coupling reactions have been used 
to prepare dienoates in a stereoselective fashion. Cross-coupling conquered the coupling 
of dienes from some of the very first disclosures of these reactions. As early as 1975, 
Heck reported one of the first disclosures of Z-dienoate synthesis using traditional Heck 
coupling conditions by synthesizing dimethyl (E,Z)-2,4-nonadienoate with several 
different Z-alkenes and methyl acrylate.31 The following year, Negishi reported the cross-
coupling of alkenes to make a variety of dienes.32 However, while only one dienoate 
example was shown in this disclosure, it was a (2E,4E)-dienoate.  
Following on from these reports, a stereoselective cross-coupling reaction for the 
synthesis of conjugated dienes was published by Tûyet in 1985 when he disclosed the 
Heck coupling of several vinylic carbonyls with alkenyl halides using what he termed 
“Solid-Liquid Phase Transfer Conditions.”33 The single dienoate example from the 
molecules reported in this paper is shown in Scheme 1.14. Using vinylic ester 1.27 in 
slight excess, he subjected both this olefin and the Z-alkenyl halide (1.28) to 6 mol % of 
Pd(OAc)2 with potassium carbonate and tetrabutylammonium chloride in dmf and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
31 Dieck, H. A.; Heck, R. F. J. Org. Chem. 1975, 40, 1083−1090. 
32 Baba, S.; Negishi, E. J. Am. Chem. Soc. 1976, 98, 6729−6731. 
33 Tûyet, J. Tetrahedron Lett. 1985, 26, 2667−2670. 
	   18	  
Scheme 1.14. Cross-Coupling of a Z-Alkenyl Halide and a Vinylic Carbonyl  by Tûyet
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1.27
1.28
Pd(OAc)2 (6 mol %)
K2CO3, NBu4Cl
dmf, rt, 1 h
O
MeO
n-Bu
1.29
 95:5 Z:E
90% yield
+
Scheme 1.15. Stereoselective Cross-Coupling to Generate Dienoates by Stille
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allowed the reaction to proceed for 1 h under N2 (as opposed to 12.5 h needed by Heck to 
make the same product). From this reaction he was able to obtain the product in 90% 
isolated yield with a Z:E ratio of 95:5. Recently, Mori used this method to prepare similar 
dienoates.34  
 
 
 
 
After Tûyet’s report, Stille and coworkers reported the cross-coupling of alkenyl 
halides with alkenyl tin reagents under the influence of a palladium catalyst in 1987.35 
The three (E,Z)-dienoates synthesized in the paper along with the general conditions 
required to achieve reaction are shown in Scheme 1.15. Using the E-alkenyl iodide 1.30 
they were able to cross-couple the Z-alkenyl tin reagent 1.31 to generate the (2Z,4E)-
ethyl dienoate in high yield and with complete selectivity. Using the corresponding Z-
alkenyl iodide and coupling this with alkenyl tin reagents such as 1.31 or its 
corresponding E isomer provided products 1.34 and 1.33, respectively, with complete 
stereoretention and moderate yield. 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
34 Mori, K. Tetrahedron 2012, 68, 1936−1946.  
35 Stille, J. K.; Groh, B. L. J. Am. Chem. Soc. 1987, 109, 813−817.  
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Scheme 1.16. Use of Stille Coupling to Generate Diene Framework in Paterson's (−)-Dictyostatin Synthesis
I
OPMBO
TBSO
O
OH
TBS
1.35
Bu3Sn CO2TIPS
1.36
CuTC (5 equiv)
nmp, rt, 14 h
OPMBO
TBSO
O
OH
TBS
CO2H
1.37
99% yield
In 2010, Paterson and coworkers reported using a similar strategy on their way to 
the molecule (−)-dictyostatin.36 As shown in Scheme 1.16, after preparing alkenyl iodide 
intermediate 1.35 and subjecting that to alkenyl stannane 1.36 and excess of CuTC, they 
were able to obtain the desired dienoic acid 1.37 in 99% isolated yield. They go on to say 
that this product was contaminated with tin residues but was used with these residues 
regardless without any adverse effects seen. While not a catalytic transformation, this 
example serves to illustrate that this strategy can be applied in a synthesis setting for the 
synthesis of dienoates and dienoic acids in a stereoselective fashion. 
 
 
 
 
 
Suzuki and coworkers also reported their own reaction towards the synthesis of 
2,4-dienoic esters in a stereoselective fashion in 198537 and later on in 1989.38 Using both 
E- and Z-alkenyl bromides, they were able to couple these to alkenyl boronates using a 
standard palladium catalyst and phosphine ligand to generate a variety of (2,4)-dienoic 
ester products in high yields and high stereoselectivity, one of which (1.40) is shown in 
Scheme 1.17. All of the dienoates reported are substituted with aliphatic chains at the 4-
position. No other functionalized molecules are reported. Suzuki notes that significant 
optimization needed to occur before high stereoselectivities were achieved. In some cases 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
36 Paterson, I.; Britton, R.; Delgado, O.; Gardner, N. M.; Meyer, A.; Naylor, G. J.; Poullennec, K. G. 
Tetrahedron 2010, 66, 6534−6545. 
37 Suzuki, A. Pure Appl. Chem. 1985, 57, 1749.  
38  Yanagi, T.; Miyaura, O. N.; Suzuki, A. Bull. Chem. Soc. Jpn. 1989, 62, 3892−3895. 
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Scheme 1.17. Stereoselective Cross-Coupling to Generate Dienoates by Suzuki
Br
CO2Et
+
n-Bu B(cat)
Pd(OAc)2 (3 mol %)
dppf (3 mol %)
K2CO3 
75% EtOH, 24 h, rt
n-Bu
CO2Et
>99:1 Z:E
1.401.39
1.38
73% yield
Scheme 1.18. Suzuki Coupling Strategy Employed in the Synthesis of (−)-Dictyostatin
OTBSTBSO
B(OH)2
1.41
CO2EtI
PdCl2/dppf
K2CO3
OTBSTBSO
CO2Et
1.4270% yield
they saw stereoscrambling when starting with a Z-alkenyl bromide and using conditions 
other than those reported to effect the coupling. 
 
  
 
 
 
The strategy of constructing dienoates via Suzuki coupling has been used in a 
different route towards the anticancer agent (−)-dictyostatin. In 2007, Ramachandran and 
coworkers used a very similar method to that reported by Suzuki in 1989 to construct the 
Z olefin of the dienoate in that molecule.39 As shown in Scheme 1.18, after obtaining 
intermediate 1.41 through hydroboration of the corresponding alkyne, they then subjected 
the resulting boronic acid to the palladium catalyst and the Z-alkenyl iodide shown to 
obtain the desired product, 1.42, in 70% yield and as one isomer.  
 
 
 
 
In 2006, Jung and coworkers also reported a stereoselective synthesis of nona-
(2E,4Z)-tert-butyl dienoate using a similar strategy as Suzuki. However, they were able 
to affect the cross-coupling with the alkenyl boronate 1.43 and the unsubstituted tert-
butyl acrylate 1.44, instead, to obtain the product (1.45) in exceptional yield and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
39 Ramachandran, P. V.; Srivastava, A.; Hazra, D. Org. Lett. 2007, 9, 157−160. 
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Scheme 1.20. Sequential Halogenation/Heck Reaction
CO2Me
LiI-HOAc
CH3CN, reflux
1.46
CO2MeI
1.47
Ph
Pd(OAc)2 (5 mol%)
Ag2CO3, CH3CN, rt, 24 h
+
1.48
CO2Me
Ph
94% yield
1.49
CO2Me
75% yield
1.50
O
CO2Me
H
O
89% yield
1.51
CO2Me
MeO
O
81% yield
1.52
Other dienoates prepared:
Scheme 1.19. Oxidative Palladium Catalysis to Generate Dienoates
n-Bu
B(pin)
1.43
+
1.44
Pd(OAc)2 (5 mol %)
O2, dma
50 °C, 8 h
1.4591% yield
n-Bu
O
O
O
O
stereoselectivity (Scheme 1.19).40 This is the only example of an (E,Z)-dienoate in this 
disclosure. 
 
 
 
 
 
Along with the traditional cross-coupling approaches described above, there have 
been a handful of disclosures describing sequential, one-pot preparations to afford 
dienoates in a stereoselective fashion. In 1992 Lu and coworkers reported a one-pot 
alkyne halogenation/Heck reaction to generate (2Z,4E)-dienoic acid derivatives.41 As 
shown in Scheme 1.20, a variety of dicarbonyl molecules were made and isolated in high 
yield and with complete stereoselectivity using this procedure.  
 
 
 
 
 
 
One of the more recent developments in transition-metal catalyzed reactions to 
stereodefined dienoates came in 2011 from Negishi and coworkers.42 In this disclosure 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
40 Yoo, K. S.; Yoon, C. H.; Jung, K. W. J. Am. Chem. Soc. 2006, 128, 16384−16393. 
41  Lu, X.; Huang, X.; Ma, S. Tetrahedron Lett. 1992, 33, 2535−2538. 
42 Wang, G.; Mohan, S.; Negishi, E. Proc. Nat. Acad. Sci. U.S.A 2011, 108, 11344−11349. 
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Scheme 1.21. Dienoate Synthesis Via Alkyne Elementometalation/Pd Cross-Coupling
n-Hexn-Hex
i-Bu2AlH-ZrCp2Cl2
ZrCp2Cl
1.53 1.54
PEPPSI (1 mol%)
thf, rt, 12 h
CO2Et
n-Hex
1.56
 >98% (2Z,4E)
n-Hex
CO2Et
HH 1) n-Hex2CuLi
2) I2
n-Hex I
1) t-BuLi (2 equiv)
Et2O, -78 °C, 20 min
2) ZnBr2 (0.7 equiv)
thf/Et2O, 30 min
-78 to 0 °C
Br CO2Et
Br CO2Et
PEPPSI (1 mol%)
thf, rt, 12 h
PEPPSI (1 mol%)
thf, rt, 12 h
Br
CO2Et
1.57 1.58
1.60
n-Hex
CO2Et
1.62
 >98% (2E,4Z)
 >98% (2Z,4Z)
85% yield
90% yield
85% yield
thf, 0 °C, 30 min
1.55
1.59
1.61
they were able to prepare all four stereoisomers of ethyl undeca-(2,4)-dienoate via alkyne 
elementometalation followed by cross-coupling using a palladium catalyst. Using a 
strategy very similar to that reported by Lu above, after performing hydrozirconation on 
n-hexyl acetylene and subjecting that to standard Negishi cross-coupling conditions 
(Scheme 1.21), undeca-(2Z,4E)-dienoate 1.56 was isolated in exceptional yield and 
stereoselectivity (85% yield, >98% 2Z,4E). To prepare the other stereoisomers of the 
same dienoate, they first allowed acetylene to undergo carbocupration followed by 
iodination to generate the Z-alkenyl iodide. They then subjected this alkenyl iodide to two 
different cross-coupling partners, the E-alkenyl bromide (1.59) and the Z-alkenyl bromide 
(1.61) along with Negishi cross-coupling conditions to obtain their respective products, 
undeca-(2E,4Z)-dienoate 1.60 and undeca-(2Z,4Z)-dienoate 1.62 both in high yield and 
exceptional stereoselectivity. 
 
 
 
 
 
 
 
 
Before accepting the palladium-catalyzed cross-coupling reactions as the gold 
standard for preparing Z-dienoates, there are several drawbacks to these reactions that 
must be mentioned. The first is cost. Palladium is an expensive metal and it may not be 
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feasible to perform such reactions on a large scale due to cost. Another significant 
problem with these reactions concerns the limited scope for these types of reactions in the 
literature. Almost every example discussed applies only a straight-chain aliphatic 
coupling partner. When working on a more complex molecule than the examples shown 
above, this is not the greatest precedent to go by when deciding how to make the Z-
dienoate scaffold. These reactions also need to have the geometry of the olefin coupling 
partner set before the cross-coupling event and even then it is possible that isomerization 
may occur during the coupling. In order to prepare the olefin containing the Z geometry, 
it will require more steps and time for the chemist to prepare the substrate (such as the 
last example from Negishi shown above). Lastly, these reactions have modest functional 
group tolerance. If chelating moieties exist in the substrate, this may affect catalyst 
activity. While these reactions may appear to be reliable options, caution must be 
considered before attempting to use them. They do offer an alternative disconnection to 
the strategies discussed above, however. 
 
1.3.3 Alternative Strategies to Preparing Z-Dienoates  
 While Still-Gennari olefination and palladium-catalyzed cross-coupling reactions 
are the two biggest methods by which Z-dienoates are prepared, there are several other 
reports in the literature of strategies to prepare these motifs that must be considered. 
Although they are rarely used in a synthesis setting, they are still viable options to 
consider if the alternatives fail. The remainder of this section for this chapter will 
examine these reported, but not often considered, alternatives. 
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Scheme 1.22. Lindlar Reduction Reported in the Synthesis of (−)-Dictyostatin
HO
OTBS CO2Et
Pd(CaCO3)/Pb
isoquinoline, H2 atm
EtOAc, rt, 15 min
1.63
HO
OTBS
CO2Et
1.64
98% yield
1.3.3a Lindlar Reduction 
 Although a popular choice when making Z-acrylates, the Lindlar reduction is not 
used as frequently to generate Z-dienoates as the strategies mentioned above. However, 
there are still several examples in the literature that should be addressed. In their 
synthesis towards (−)-dictyostatin, Yadav and coworkers reported a Lindlar reduction on 
intermediate 1.63 (Scheme 1.22), which had been prepared through cross-coupling of the 
alkyne to the corresponding alkenyl iodide.43 Following reaction for 15 minutes and 
purification, the (2Z,4E)-dienoate 1.64 was obtained in 98% yield. This fragment was 
then combined with a larger fragment through macrolactonization to afford the target 
molecule. 
 
  
 
  
Another example of preparing a Z-dienoate in a synthesis setting via a Lindlar 
reduction comes from the synthesis of the immunosuppressant (−)-pateamine A by Liu 
and coworkers.44 After preparing enyne 1.65 (Scheme 1.23), they subjected the 
macrocycle to Lindlar reduction conditions and were able to obtain 1.66 in >99% yield 
after 14 hours of reaction. This intermediate was then carried through to the completion 
of the synthesis. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
43 Yadav, J. S.; Rajender, V. Eur. J. Org. Chem. 2010, 2148−2156. 
44 Romo, D.; Rzasa, R.; Shea, H. A.; Park, K.; Langenhan, J. M.; Sun, L.; Akhiezer, A.; Liu, J. O. J. Am. 
Chem. Soc. 1998, 120, 12237−12254.  
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Scheme 1.23. Lindlar Reduction Reported in the Synthesis of (−)-Pateamine A
N
S
Br
O
O
O
O
BocHN
1.65
N
S
Br
Pd(CaCO3)/Pb
H2, MeOH, 14 h
OO
O
O
BocHN
1.66
>99% yield
Scheme 1.24. Lindlar Reduction by Ramachandran
EtO
O
O
OEt
Pd(CaCO3)/Pb
quinoline, H2
OEtO
OEt
O
99% yield1.67 1.68
hexanes
 
 
 
 
 
In a short report from 2005, Ramachandran and coworkers reported the synthesis 
of an (E,Z)-diene dioate through Lindlar reduction on the way to an (E,Z)-muconic acid 
diester.45 After obtaining the enyne dioate 1.67 (Scheme 1.24) and subjecting it to Lindlar 
reduction conditions, they were able to obtain the diene dioate 1.68 in quantitative yield. 
This was the only dienoate they generated from the Lindlar reduction in this report. 
 
 
 
 
 
 
 One final example comes from a report in 2008 from Micalizio and coworkers 
from their synthesis of the antitumor agent (+)-macbecin I.46 After performing the Lindlar 
reduction on alkyne 1.69, they were able to obtain the desired product 1.70 in 93% yield. 
It was then taken forward to complete the synthesis. Working on a natural product in the  
same class as (+)-macbecin, Panek and coworkers used the same strategy to obtain a Z-
dienoate. However, the Lindlar reduction they performed was on an enyne-acid on their 
way to the anticancer agent geldanamycin.47 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
45  Ramachandran, P. V.; Rudd, M. T.; Reddy, M. V. R. Tetrahedron Lett. 2005, 46, 2547−2549. 
46  Belardi, J. K.; Micalizio, G. C. Angew. Chem. Int. Ed. 2008, 47, 4005−4008. 
47  Qin, H.-L.; Panek, J. S. Org. Lett. 2008, 10, 2477−2479. 
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Scheme 1.25. Lindlar Reduction Reported by Micalizio in the Synthesis of (+)-Macbecin
TBSO
OH
OMe
O
1.69
Pd(CaCO3)/Pb
quinoline, H2
C6H6, rt, 2 h
TBSO
OH
OMeO
1.70
93% yield
 
 
 
 
 
 
 
 
 
1.3.3b Synthesis of Dienoates From Allenes 
 
 Another alternative to the above mentioned procedures to stereoselective dienoate 
preparation came from the Takeda group in 1982 in which they were able to prepare 
several (2E,4Z)-dienoates in high stereoselectivity and high yield after subjecting a 
variety of allenes they had prepared to several equivalents of aluminum oxide (Scheme 
1.26).48 This method has not seen widespread use in the literature for two important 
reasons. The first being that this reaction requires the preparation of allenes, which are 
not commercially available and require even more steps to prepare than the alkyne 
methodologies mentioned previously. The second reason this method has not seen 
widespread use is due to the limited scope they show in the paper. The only substrates 
shown in this report are aliphatic allenes. No functionality was added to the allenes to 
broaden the scope of the reaction, perhaps due to the limited synthetic technology at the 
time.  
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
48  Tsuboi, S.; Masuda, T.; Makino, H.; Takeda, A. Tetrahedron Lett. 1982, 23, 209-212. 
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Scheme 1.26. Synthesis of Dienoates From Aliphatic Allenes
Me • CO2Me'
Al2O3 (5-10 equiv)
benzene, 80 °C, 2-6 h
Me
OMe
O
1.71 1.72
57% yield, >99% 2E,4Z
OMe
O
Me
82% yield, 96% 2E,4Z
OMe
O
80% yield, 96% 2E,4Z
Me OEt
O
1.73 1.74
Me
1.75
69% yield, 93% 2E,4Z
OEt
OMe
1.76
82% yield, >99% 2E,4Z
Other dienoates prepared in this report:
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.3c Cuprate Additions to Alkynes 
 
 One last method that was developed in the early 1970s deals with the 
stereoselective synthesis of (E,Z)-dienoates through vinyl cuprate additions to α,β-
unsaturated carbonyls, specifically alkynes. This method of dienoate synthesis was first 
reported by Degen and coworkers in 1971.49 Using a method disclosed by Whitesides50 to 
generate Z-alkenyl cuprates 1.77 and 1.80 (Scheme 1.27), they then subjected these 
alkenyl cuprates to ethyl propiolate (1.78) to generate dienoates 1.79 and 1.81 in high 
yield and high stereoselectivity. In all cases, even those that did not involve generating a 
dienoate, they saw 95% or greater retention of stereochemistry in the final product.  
Normant and coworkers studied the synthesis of similar dienoates using the 
method developed by Degen in 1981.51 However, as with the products obtained by 
Degen, these products were exclusively aliphatic dienoates. With a limited scope 
explored for this type of reaction, it has not been used to a great extent in a synthesis 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
49 Näf, F.; Degen, P. Helv. Chim. Acta 1971, 54, 1939−1949. 
50 Whitesides, G. M.; San Filippo Jr., J.; Casey, C. P.; Panek, E. J. J. Am. Chem. Soc. 1967, 89, 5302−
5303. 
51 Alexakis, A.; Cahiez, G.; Normant, J. F. Tetrahedron 1981, 36, 1961−1969. 
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Scheme 1.27. Vinyl Cuprate Addition to α,β-Unsaturated Esters
1.77
+ CO2Et
1.78
Et2O, 15 min, −10 °C Me
CO2Et
 95% (2E,4Z)
1.79
1.80
+ CO2Et
1.78
Et2O, 15 min, −10 °C n-pent
CO2Et
95% (2E,4Z)
1.81
n-pent 2CuLi
77% yield
90% yield
2CuLi
setting, as more developed and explored techniques of preparing dienoate architectures 
are available. 
 
 
 
 
 
 
 
 
 
 
 
1.4 Traditional Preparation of Acrylates and Dienoates by Olefin Cross-
Metathesis  
 
 There have been several disclosures in the literature regarding generating α,β- as 
well as α,β,γ,δ-unsaturated ester compounds via olefin cross-metathesis (coupling two 
olefins from separate molecules into one) using well-defined catalysts. These catalysts, 
such as the Schrock bis-alkoxide molybdenum complex,52 Grubbs’ second-generation 
ruthenium complex,53 and the Hoveyda-Grubbs phosphine-free complex,54 generally give 
the thermodynamic ratio of Z and E isomers (in some cases even high E selectivity), in 
the final product mixture from the cross-metathesis event. One of the earliest examples of 
cross-metathesis to generate Z-acrylates was reported by Grubbs and coworkers in 
2000.55 Using methyl acrylate 1.27 and subjecting it to 2.0 equivalents of the benzylated 
alcohol 1.82 and a modified version of the Grubbs second generation complex 1.83, they 
were able to obtain the cross product 1.84 in high yield but selectivity proved to be an 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
52 Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; O’Regan, M. J. Am. Chem. Soc. 
1990, 112, 3875−3886. 
53 Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956.  54	  Garber, S. B.; Kingsbury. J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168−8179. 
55 Chatterjee, A. K.; Morgan, J. P.; Scholl, M.; Grubbs, R. H. J. Am. Chem. Soc. 2000, 122, 3783−3784. 
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Scheme 1.28. Ru-Catalyzed Cross-Metathesis of α,β-Unsaturated Esters
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MeO
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1.27
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7
1.84
1.87
1.86
1.85
+
1.83
1.83
91% yield
62% yield
issue, giving a thermodynamic ratio of the E- and Z-acrylate olefin (Scheme 1.28). 
Among a variety of other unsaturated carbonyl cross products they showed, they also 
obtained 1.87 in decent yield and in high selectivity in favor of the E cross product. All of 
the products they obtained from the reaction are almost all exclusively E-selective; 
highlighting how the E isomer is energetically preferred. 
 
 	  	  	  	  	  	  	  	  
 
Another example of unsaturated ester cross-metathesis comes from the Lipshutz 
group in 2011.56 In this report they perform a cross-metathesis with acrylate 1.44 and the 
corresponding methyl acrylate with a variety of aryl olefins under the influence of the 
Grubbs second-generation ruthenium complex 1.89 and, as shown in Scheme 1.29, they 
obtained every cross product in very high E selectivity. Every product they disclose is 
less than 5% of the corresponding Z isomer. 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
56  Voigtritter, K.; Ghorai, S.; Lipshutz, B. H. J. Org. Chem. 2011, 76, 4697−4702. 
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Scheme 1.30. Ru-Catalyzed Cross-Metathesis of Dienoates
Me
CO2Me
MeO
CO2Me
CO2Me
CO2Me CO2Me
CH2Cl2
40 °C, 8 h
68% yield, >95:5 E:Z
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Scheme 1.29. Ru-Catalyzed Acrylate Cross-Metathesis
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Other dienoates prepared in this report:
 
 
 
 
 
 
 
There are fewer reports of dienoate cross-metathesis in the literature. However, 
one notable paper from the Curran group detailed a cross-metathesis protocol to generate 
(2Z,4E)-dienoates.57 As shown in Scheme 1.30, they were able to prepare a large variety 
of these products in moderate yields with high E selectivity using the Grubbs second-
generation ruthenium catalyst 1.89. They were looking to functionalize the E olefin of the 
dienoate by crossing a large variety of 1,2-disubstituted E olefins with dienoate 1.94. This 
gave them high E selectivity due to the original E geometry of the cross partner as well as 
the general preference from the catalyst towards the E isomer.  
 
 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
57 Moura-Letts, G.; Curran, D. P. Org. Lett. 2007, 9, 5−8. 
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Another known disclosure of cross-metathesis to generate dienoates was 
published by the Grubbs group in 2005 with their second-generation ruthenium complex 
1.89.58 Using this protocol they were able to synthesize a variety of (E,E)-dienoates in 
moderate yield and varying selectivities (Scheme 1.31). In some cases, the catalyst 
loading had to be raised to 10 mol % to achieve high conversion (such as to generate 
products 1.102b and 1.102d). Even when they use a cis olefin to undergo the cross-
metathesis with dienoate 1.101, they still obtain the trans product as the major product 
(1.102c and 1.102d), albeit with a slightly lower preference for that isomer. They also 
show the example of performing a cross-metathesis with 1.103 and alkenyl acetate 1.104 
with the same catalyst and observing that the catalyst does perform metathesis with the 
internal olefin of the dienoate moiety and gives an 80:20 mixture of 1.105:1.106. No 
yield was given for this reaction. Cossy and coworkers also reported a variety of (E,E)-
dienoates in 2006 using the Hoveyda-Grubbs phosphine-free complex.59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
58 Funk, T. W.; Efskind, J.; Grubbs, R. H. Org. Lett. 2005, 7, 187-190. 
59 Ferrié, L.; Amans, D.; Reymond, S.; Bellosta, V.; Capdevielle, P.; Cossy, J. J. Organomet. Chem. 2006, 
691, 5456−5465. 
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Scheme 1.31. Cross-Metathesis of Dienoates Reported by Grubbs
Ph Ru
NMesMesN
Cl
Cl
PCy3
 
CH2Cl2
reflux, 12 h
5.0 mol %
Me
Br
O
OEt+G G
Br
OEt
O
1.101
Ph
Br
OEt
O
65% yield, 91:9 E:Z
1.102b
Br
OEt
O
70% yield, 88:12 E:Z
1.102c
Br
OEt
O
AcO Cl
48% yield, 86:14 E:Z
1.102d
10 mol % Ru 10 mol % Ru
(3 equiv)
Br
OEt
O
Ph
1.102a
68% yield, 89:11 E:Z
(2 equiv of dichlorobutene)
1.89 1.102
G, H
Me
O
OEt
+
OAc
1.103
1.104
Ph Ru
NMesMesN
Cl
Cl
PCy3
 
CH2Cl2
reflux, 12 h
10 mol %
O
OEtAcO
3
1.105
 91:9 E:Z
AcO
1.106
O
OEt
3
 >95:5 E:Z
+
80:20 mixture of 1.105:1.106
1.89
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There have also been several tandem approaches to the synthesis of dienoic esters 
disclosed that should be mentioned involving metathesis processes. One of which, by 
Snapper and coworkers in 2007, reported a tandem cross-metathesis (using the modified 
Grubbs second generation complex 1.83) followed by subsequent Wittig olefination to 
generate a variety of (E,E)-dienoates, several of which are shown below (Scheme 1.32).60 
That same year, Andrade and coworkers published a very similar study as that by the 
Snapper group using the same transformations to synthesize (E,E)-dienoic esters.61 
 
  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
60 Murelli, R. P.; Snapper, M. L. Org. Lett. 2007, 9, 1749−1752. 
61 Paul, T.; Andrade, R. B. Tetrahedron Lett. 2007, 48, 5367−5370. 
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Scheme 1.32. Tandem Cross-Metathesis/Wittig Olefination by Snapper
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1.5 Research Goals 
  
 Virtually all of the methodologies shown above for the synthesis of Z-α,β- and 
(E,Z)-α,β,γ,δ-unsaturated esters have drawbacks and challenges associated with 
performing them. Some are limited by cost, while others are limited by how 
stereoselective they can be; yet others require multiple steps to achieve the desired 
starting material. The ability to make conjugated unsaturated esters in a Z-selective 
fashion is of great importance to those in the synthetic community, yet the most advanced 
reactions for these transformations are often found lacking when it comes to delivering 
the desired product with the desired stereoselectivity. We saw this as an opportunity to 
use our latest olefin metathesis catalysts to develop the first Z-selective olefin cross-
metathesis of acrylates. If this was successful, we then would look to pursue development 
of the first Z-selective cross-metathesis of dienoates. 
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2. Development of a Stereoselective Olefin Cross-Metathesis of 
Unsaturated Esters  
 As stated in chapter 1 of this thesis, acyclic Z olefins are generally higher in 
energy than their corresponding E isomer. This makes methods that can stereoselectively 
prepare Z olefins of great importance to the chemistry community at large. Before 
exploring how we developed the protocol for Z-selective cross-metathesis (CM) of 
acrylates and conjugated dienoates, it is important to discuss the foundation for this 
project. This includes the challenges associated with developing a stereoselective olefin 
metathesis catalyst and how our group overcame these challenges in recent years. 
 
2.1 Background 
 There are two big challenges to overcome when attempting to design a 
stereoselective olefin cross-metathesis catalyst. The first is that the catalyst must be able 
to access the kinetic Z product over the thermodynamic E product. In general, the Z 
isomer is roughly 1.0 kcal/ mol higher in energy than its corresponding E isomer (for 
acyclic olefins).62 This generally gives a thermodynamic ratio of roughly 83:17 E:Z at 
room temperature. Without the desired kinetic selectivity, the catalyst would be just as 
efficient as the catalysts already reported and would be of no benefit, assuming no control 
is placed upon the selectivity from the substrate itself. 
 The second challenge, as shown in Scheme 2.1, associated with developing a 
stereoselective olefin metathesis catalyst concerns chemoselectivity. In order to prevent 
significant homocoupling of one olefin, the catalyst must be able to differentiate between 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
62 Turner, R. B.; Jarrett, A. D.; Goebel, P.; Mallon, B. J. J. Am. Chem. Soc. 1973, 95, 790−792.  
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Scheme 2.1. Chemoselectivity Challenges in Stereoselective Catalyst Design
+
+
the two olefins and prefer to perform the cross-metathesis as opposed to homocoupling of 
the same olefin. Finally, to ensure that Z selectivity does not erode once the Z product has 
been formed, the catalyst must be able to differentiate between the product and the two 
starting material olefins. While kinetic selectivity is vital when designing a 
stereoselective metathesis catalyst, chemoselectivity is just as important, as kinetic 
selectivity could be erased through post-metathesis isomerization.  
 
 
 
 
 
 
 
 
 
 As little as a decade ago, synthetic chemists had to find alternative ways of 
synthesizing Z olefins stereoselectively as the most advanced olefin metathesis catalysts 
at the time could not achieve the needed kinetic selectivity (as exemplified in the 
examples in chapter 1 of this thesis). While chemoselectivity was not an issue for these 
catalysts, there was no answer to the challenge of overcoming the thermodynamic 
preference for the E isomer. The catalysts at the time could only deliver the 
thermodynamic ratio of Z:E olefins for many transformations and, in most cases, were 
highly E-selective. 
 This all changed in 2008 when our group disclosed the development of 
stereogenic-at-Mo monoaryloxide monopyrrolide (MAP) complexes. In this report, we 
show that these MAP complexes (2.3), are generated in situ from a molybdenum bis-
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pyrrolide complex (2.1) and a monoprotected diol (2.2) in high conversion and in high 
diastereoselectivity (Scheme 2.2).63 These complexes were originally developed for 
enantioselective ring-closing metathesis (RCM) of the potent vasodilator (+)-
quebrachamine. After obtaining triene 2.4 (Scheme 2.3), we subjected this intermediate 
to 1.0 mol % of the MAP complex 2.5 and were able to affect the RCM of the triene to 
generate 2.6 in high enantioselectivity and in high yield. Following hydrogenation we 
were able to obtain the final natural product (2.7) in exceptional yield. It should be noted 
that prior to the development of the MAP complexes, the most advanced molybdenum 
and ruthenium metathesis catalysts at the time were ineffective at performing the 
necessary ring closure. 
 
 
 
 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
63 Malcolmson, S. J.; Meek, S. J.; Sattely, E. S.; Schrock, R. R.; Hoveyda, A. H. Nature 2008, 456, 933−
937.  
	   37	  
TBSO
O
1.0 mol %
(2 equiv)
C6H6, 22 °C, 1 h O
TBSO
96% conv, 67% yield 
98:2 er, >98:2 Z:E
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Following on from our studies on enantioselective RCM, we then were able to 
show these catalysts were effective at another transformation, enantioselective ring-
opening/cross-metathesis  (ROCM).64 By subjecting a strained oxabicycle such as 2.8 
(Scheme 2.4), and 2 to 10 equivalents of a substituted styrene to MAP complex 2.3, a 
large variety of pyrans (2.10−2.13) could be generated in moderate to high yield and high 
enantioselectivity. However, it was the discovery that these products were also formed in 
exceptionally high Z selectivity that was very intriguing. From this study, we proposed 
that the Z selectivity from these complexes arises from the size differential between the 
small imido ligand and the large, freely rotating aryloxide ligand (Scheme 2.5). This 
rotating aryloxide ligand sweeps out a large steric space that prevents the incoming olefin 
substituents from pointing down towards the aryloxide (I), instead orienting itself 
towards the smaller imido group to minimize steric interactions (II). Following 
metallocyclobutane collapse, the desired Z olefin is released and the catalytic cycle 
continues (III). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
64  Ibrahem, I.; Yu, M.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3844−3845. 
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Scheme 2.5. Proposed Model for Stereoselectivity for MAP Complexes
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Scheme 2.6. Z-Selective CM of Enol Ethers
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Upon finishing the ROCM project and using what we had learned from that study, 
our group then began to explore developing a Z-selective transformation for the more 
difficult cross-metathesis reaction. In 2011, we disclosed the cross-metathesis of enol 
ethers with a variety of terminal cross partners to generate products such as 2.17 in high 
yield and exceptionally high Z selectivity (Scheme 2.6).65 Product 2.17 was eventually 
carried forth as an intermediate to the synthesis of the potent anti-oxidant C18 
(plasmalogen)-16:0 (PC).  
  
 
 
 
 
 
 Following our development of the Z-selective cross-metathesis of enol ethers, we 
then explored developing stereoselective CM reactions for other commonly used 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
65  Meek, S. J.; O’Brien, R. V.; Llaveria, J.; Schrock, R. R.; Hoveyda, A. H. Nature 2011, 471, 461−466. 
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substrates in organic synthesis. These studies lead to publications on the Z-selective 
cross-metathesis of allylic ethers,66 followed closely by allyl and vinyl pinacol boronic 
esters (B(pin)).67 The latter of the two studies showed that metathesis combined with 
cross coupling could be a powerful tool towards rapidly building complexity in synthesis. 
After these studies, we became interested in developing metathesis protocols for 
unsaturated ester olefins. From our initial investigations into the metathesis of these 
motifs came a report in 2014 on the Z-selective RCM of both macrocyclic acrylates and 
dienoates. Using a recently developed pentafluorophenyl imido molybdenum complex68 
containing a hexamethylterphenoxide ligand (2.18), our group synthesized a large variety 
of macrocyclic Z-acrylates and macrocyclic (E,Z)- and (Z,E)-dienoates in relatively high 
Z selectivity and isolated these macrocycles in moderate to high yield (Scheme 2.7).69  
 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
66  Mann, T. J.; Speed, A. W. H.; Schrock, R. R.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2013, 52, 8395−
8400 
67  Kiesewetter, E. T.; O’Brien, R. V.; Yu, E. C.; Meek, S. J.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. 
Soc. 2013, 135, 6026−6029. 
68  Yuan, J.; Schrock, R. R.; Gerber, L. C. H.; Müller, P.; Smith, S. Organometallics 2013, 32, 2983−2992. 
69  Zhang, H.; Yu, E. C.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 16493−16496. 
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Scheme 2.7. Z-Selective RCM of Macrocyclic Acrylates and Dienoates
O
O
N
MoN Ph
O
FF
F F
F
5.0 mol %
C6H6 (2.0 mM), 
100 torr, 2h
O
O
12 examples
44−70% yield of pure Z isomer
79−90% Z-selectivity
O
O N
MoN Ph
O
FF
F F
F
C6H6 (2.0 mM), 
100 torr, 2h
O
O
4 examples
50−71% yield
up to 98:2 Z:E
3.0−5.0 mol %
2.18
2.18
nn
n= 0, 3, 5, 6, 7, 8, 13
n n
n= 0, 1, 3, 4
 
 
 
 
 
 
 
 
 
 
 
2.2 Development of the Z-Selective Cross-Metathesis of Acrylates 
 While the RCM reaction of macrocyclic acrylates and dienoates was being 
pursued, we began investigating the development of a separate CM protocol for acyclic 
unsaturated esters. While RCM and CM are somewhat similar reactions, the conditions 
used for both reactions are vastly different. RCM reactions require high dilution (as 
shown in the RCM in Scheme 2.7) to avoid homocoupling of the macrocycle, while CM 
requires high concentrations to facilitate the two olefins finding each other in a sea of 
both solvent and the other olefin cross partner. In RCM there is only one substrate added 
to the reaction, while in CM there are two cross partners, allowing for easy alteration of 
stoichiometry for optimization. With this in mind, we initiated our studies on optimizing 
the reaction conditions for the acrylate CM using acrylate 2.19 and attempting to cross 
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Scheme 2.8. Optimization of Acrylate CM Stoichiometry
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that with 1-decene (2.20) under the influence of the MAP complex shown in Scheme 2.8 
(2.16).70 When three equivalents of 1-decene were used with one equivalent of acrylate 
2.19, the reaction proceeded to near 50% conversion to product with a Z:E ratio of 78:22 
after 4 hours. When the stoichiometry was reversed and three equivalents of acrylate 
were added to one equivalent of 1-decene, the conversion did not proceed to even half of 
that with the other stoichiometry in the same amount of time. This lead to the hypothesis 
that the Lewis basic carbonyl oxygen of the acrylate was possibly coordinating with the 
Lewis acidic molybdenum center of the MAP complex, shutting down its reactivity. 
Moving forward, the non-acrylate cross partner would be used in excess. 
  
 
 
 
 
 
 
Moving on with the conditions screen for the acrylate CM reaction, using the 
stoichiometry established from the above-described study, a variety of catalysts were 
screened to find the optimal catalyst for this transformation. As shown in Scheme 2.9, 
starting out with the less reactive tungsten complex (2.22), no conversion to product was 
observed after 4 h. Moving to the molybdenum dimethylphenylimido complex 2.23, 
similar conversion to 2.21 as when attempting to make the product with the TBS-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
70  Yu, E. C. unpublished results. 
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protected bromo binol derived dimethylphenylimido complex 2.16 was observed. We 
then hypothesized that we needed to perhaps make the catalyst more reactive by 
increasing the Lewis acidity of the molybdenum center. To do this we made the para-
bromo substituted tetraphenyl phenol ligand shown in complex 2.24 and we also swapped 
the imido groups, from the dimethylphenylimido of 2.23 to the pentafluorophenylimido. 
While this catalyst gave higher conversion, the Z selectivity of the reaction suffered, 
perhaps due to post-metathesis isomerization. Tuning down the reactivity by adding the 
less electron-withdrawing hexamethylterphenoxide (HMTO) ligand to the 
pentafluorophenylimido molybdenum (complex 2.18), conversion again was lower than 
expected, however the Z selectivity was what we desired. We speculated that perhaps 
acrylate 2.19 was too big of a cross partner for the catalyst to give both high conversion 
and Z selectivity so we began pursuing other acrylates. However, we decided to continue 
the development of the acrylate CM with complex 2.18, coincidentally the same catalyst 
used for the RCM of macrocyclic acrylates and dienoates.71 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
71  Yu, E. C. unpublished results. 
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Having determined the optimal catalyst and stoichiometry for our CM reaction of 
acrylates, we then investigated the proper solvent for the reaction. As shown in Table 2.1, 
using tert-butyl acrylate 2.25, instead of acrylate 2.19, and crossing it with 1-decene 
(2.20) using 5.0 mol % of the pentafluorophenylimido HMTO complex 2.18, a variety of 
solvents were screened to determine which gave product 2.26 in the best yield and Z 
selectivity. When the reaction was performed in benzene (catalyst 0.1 M in benzene), 
conversion to product was 79% after 5 minutes although, as shown in the table, 
selectivity suffers. As the reaction time is increased to 15 minutes, conversion to product 
does not increase while Z selectivity erodes to virtually 63:35 due to post-metathesis 
isomerization. When the reaction was performed in thf, conversion after 5 minutes is near 
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5.0 mol %
2.18
2.25 2.20 2.26
Table 2.1. Solvent Screening for Acrylate CM
Entry Solvent conc. (M) conv (%) Yield (%) Z:E
1 C6H6 5 0.1
time (min)
79 62 79:21
2 C6H6 15 0.1 79 65 65:35
3 thf 5 0.025 71 53 93:7
4 thf 15 0.025 89 75 85:15
5 CH3CN 5 0.1 <2 ND ND
6 CH3CN 60 0.1 70 54 93:7
ND= Not determined
what it was at 5 minutes using benzene, yet with significantly higher Z selectivity. As the 
reaction time was increased, we saw the Z selectivity again erode, not nearly as quickly 
as with benzene, however. Moving to the more Lewis basic solvent acetonitrile, the 
reaction proceeded at a much slower rate than with benzene and thf but the Z selectivity 
was high even after one hour, indicating there is slower post-metathesis isomerization in 
acetonitrile. Looking at the data, it may appear that thf is the most optimal solvent for this 
reaction due to the fact that it produces the same results in acetonitrile after 1 hour as it 
takes 5 minutes to accomplish in thf. However, we pursued different stoichiometries in 
acetonitrile and found that the acrylate could be used in excess and the reaction gives a 
better result than when the other cross partner was used in excess.72 We decided to pursue 
the scope of the reaction in acetonitrile. 
 
 
 
 
 
 
 
 
 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
72  Yu, E. C. unpublished results. 
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Since the acrylate was the less expensive cross partner in this reaction, we sought 
to develop the scope using the acrylate in excess with the conditions described above. As 
shown in Scheme 2.10, a variety of cross partners underwent cross-metathesis with tert-
butyl acrylate 2.25 in acetonitrile with varying degrees of success. Products 2.26, 2.27, 
2.28, and 2.29 were isolated in moderate to high yields and high Z:E ratios. Shorter chain 
substrates such as the homoallylic TES ether, allyl benzene, and the para-methoxy benzyl 
ether (products 2.30, 2.31, and 2.32, respectively) gave high Z selectivity and were 
isolated in decent yield. These substrates were slower to react and required longer 
reaction times to achieve higher conversion, however. Significant reaction optimization 
needed to be undertaken to optimize the results from the cross-metatheses of products 
2.33 and 2.34. It is believed that the α−branched substrate to generate product 2.33 (vinyl 
cyclohexane) imparts greater steric pressure on the catalyst that makes it slower for 
catalyst turnover to occur. Product 2.34 may be slower to form due to the terminal diene 
substrate forming a stabilized alkylidene with the catalyst.73 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
73  Yu, E. C. unpublished results. 
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Scheme 2.10. Scope of the Acrylate CM Reaction in Acetonitrile
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2.3 Development of the Z-Selective Cross-Metathesis of Dienoates  
While looking into the scope development of the acrylate CM reaction we were 
pondering developing a reaction that could allow easy access to (2E,4Z)-dienoates, 
inspired from our attempts to synthesize diene 2.34. Chapter 1 details the significance of 
dienoate products and, seeing as there was enough of a need for such a reaction, we 
initiated our studies into the cross-metathesis of dienoates. 
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 As we had already developed a RCM protocol for macrocyclic dienoates and 
acrylates (see above) as well as a CM reaction of acrylates using the 
pentafluorophenylimido molybdenum complex 2.18, we decided to initiate our studies of 
the CM of dienoates using this catalyst.74 Looking into the scope of the cross-metathesis 
of phenyl dienoate 2.35 using three equivalents of the non-dienoate cross partner in 
benzene, we discovered that the products of the dienoate CM reaction did not isomerize 
as easily as the acrylates had. In fact, the dienoates could be run using 3.0 mol % of 
complex 2.18 and still give high conversion after 1 minute under 100 torr vacuum with 
several long-chain cross partners (see 2.36, 2.37, and 2.38 in Scheme 2.11). These 
substrates could be isolated in moderate to high yield, albeit with slightly lower 
selectivities than we were hoping for. While the homoallylic TES ether gave nice 
reactivity (see product 2.40) with slightly higher Z selectivity than the long-chain 
products described above, when the substrates were made allylic (products 2.42 and 
2.43), the conversion and yield suffered. When the non-dienoate cross partner was made 
vinylic (vinyl B(pin) of product 2.41), conversion to product was exceptional as was 
selectivity, however due to what we believe to be hydrolysis of the pinacol boronic ester 
(B(pin)) group to the boronic acid on silica gel, the yield was slightly lower than desired. 
This reaction also required more time to complete (18 h). We believe this to be a result of 
the formation of a stabilized alkylidene between the vinyl B(pin) and the active catalyst. 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
74 Our initial screening data prior to initiating our studies into the scope of the dienoate reaction showed 
that this was also the optimal catalyst, we later discovered that the dienoate used for these screening 
reactions was actually a mixture of stereoisomers and the data was not usable. 
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a Reactions were performed for 1 min.
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e Reactions were performed for 15 min.
* Isolated with ligand.
Scheme 2.11. Scope of the Dienoate CM With Complex 2.18
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After completing our initial substrate scope with complex 2.18 we began to 
wonder if this complex was indeed the optimal catalyst for this reaction due to the lower 
than desired selectivities we observed. As shown in Scheme 2.12, using phenyl dienoate 
2.35 and three equivalents of 1-decene 2.20 we began to screen a variety of our older 
generation MAP complexes for this transformation. When lowering the Lewis acidity of 
the molybdenum metal by making the o-CF3 phenylimido complex 2.44, little conversion 
to product (21%) was seen. Moving towards more electron-rich imido groups we 
subjected the olefins to complex 2.16 and saw a significant increase in conversion from 
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complex 2.44. Moving towards the slightly more electron-rich complex 2.3, the reaction 
proceeded to 82% conversion and gave the product in a 97:3 Z:E ratio. In the hopes of 
attaining even higher conversion we subjected the olefins to adamantylimido complex 
2.45 and saw 90% conversion to product with a Z:E ratio of 97:3 which provided the 
product in 83% yield. Having found the optimal imido group, we then sought to look at 
the ligand of the molybdenum complex in greater detail. Switching the TBS-protected 
bromo-binol derivative to the corresponding chloro-binol derivative (complex 2.46), we 
saw conversion to product increase slightly to 93% conversion, however both yield and Z 
selectivity were lower than when using molybdenum complex 2.45 (73% yield and 95:5 
Z:E). Seeing as the TBS-protected bromo-binol derivative gave slightly higher Z 
selectivity and was more practical to make than the corresponding chloro-binol 
derivative, we decided to pursue the dienoate CM reaction using complex 2.45.  
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Having found the optimal catalyst for the transformation, we then looked into 
screening conditions for the dienoate CM reaction. When the stoichiometry of the 
reaction was switched from 3:1 to 1:3 2.20:2.35 and the reaction was placed under a 
vacuum of 100 torr, only 9% conversion to product was observed, indicating excess of 
the dienoate leads to early catalyst decomposition (Table 2.2, Entry 2). Switching the 
stoichiometry to 1:1 and using a 100 torr vacuum, the reaction proceeded to 62% 
conversion to product, however homocoupling of the 1-decene limited conversion to 
	   51	  
O
PhO
PhO
O Me
6
N
Mo
O Br
TBSO
Br
N Ph
X mol %
pressure, 0.1 M C6H6
22 °C, 15 min
Entry Equiv 2.35 Equiv 2.20 Conditions Conv. (%) Z:E Yield (%)
1 1 3 100 torr 90 97:3 83
2 3 1 100 torr 9 >98:2 ND
3 1 1 100 torr 62 97:3 ND
mol %
5.0
5.0
5.0
4 1 3 sealed vial 79 97:3 745.0
5 1 3 100 torr 81 97:3 743.0
+
2.35 2.36
Table 2.2. Conditions Screen for Dienoate CM
2.452.20
ND= not determined
6
Me
product. Using the 3:1 2.20:2.35 stoichiometry and sealing the vial lead to 79% 
conversion with a Z:E ratio of 97:3 and provided the desired product in 74% yield (Entry 
4). Using the optimal 3:1 2.20:2.35 stoichiometry and lowering the catalyst loading to 3 
mol % using a 100 torr vacuum provided the product in 81% conversion with a high Z:E 
ratio and lead to the isolation of the desired product in 74% yield (Entry 5).  
 
 
 
 
 
 
 
 
 
 
 
 
Having screened a variety of conditions, we concluded that the acceptable conditions for 
this reaction were in fact the conditions used for the catalyst screening shown in entry 1. 
With the optimal conditions known we then moved on to developing the scope of the 
reaction. 
 
 
	   52	  
PhO
O
Br
5
PhO
O
OTBS
PhO
O
SBn
(3 equiv)
O
PhO
PhO
O G
92% conv, 85% yield 
97:3 Z:E
89% conv, 83% yield
98:2 Z:E
75% conv, 70% yield
97:3 Z:E
PhO
O
Ph
28% conva
PhO
O
88% conv, 81% yield
97:3 Z:E
PhO
O
56% conv, 50% yield
97:3 Z:E
TIPS
PhO
O
OPMB
5
3
5
OTES
Me
90% conv, 83% yield
97:3 Z:E
Me
6
52% conv,a 44% yield
98:2 Z:E
N
Mo
O Br
TBSO
Br
N Ph
(0.1 M in C6H6)
100 torr, 22 °C, 15 min
PhO
O
O
3
23% conv
+
Scheme 2.13. Substrate Scope of the Dienoate CM
2.35 2.36
2.392.37 2.38
2.47 2.40 2.48
2.42 2.43
a Reaction performed for 30 minutes
2.45
5.0 mol %
The scope of the reaction using the new conditions is shown in Scheme 2.13. A 
variety of long-chain products (2.36, 2.37, 2.38, 2.39, and 2.47) were able to be isolated 
in high yield and the reaction provided them in Z selectivities of all 97:3 Z:E or higher.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.40 was slower to form than the longer-chain products and only proceeded to 56% 
conversion in 15 minutes. When attempting to raise the conversion by running the 
reaction for 30 minutes, no significant increase in conversion was seen. However, 
virtually only one isomer was formed in this reaction and the product was isolated in 
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relatively high yield considering the lower conversion. Geraniol-derived ether was able to 
undergo efficient cross-metathesis with the dienoate, however it required 30 minutes to 
proceed to decent conversion. 2.48 was, however, able to be isolated in 44% yield and 
was afforded as one isomer. Reactions to generate both allylic dienoates 2.42 and 2.43 
did not afford the product in high enough conversion. No increase in conversion to these 
products was seen when the reaction was allowed to proceed for a longer time. However, 
as seen above in Scheme 2.11, complex 2.18 was able to generate both products in decent 
yield and Z selectivity. 
 
2.4 Conclusion 
 In conclusion, we used the latest in molybdenum metathesis catalysts to develop 
the first Z-selective CM of acrylates. Using the pentafluorophenylimido molybdenum 
complex 2.18 and performing the cross-metathesis between the two cross partners in 
acetonitrile, a large variety of Z-acrylates could be prepared in high stereoselectivity. 
Following on from our studies on acrylates we then developed the first stereoselective 
cross-metathesis of dienoates using adamantylimido molybdenum complex 2.45. Using 
these conditions several (2E,4Z)-dienoates were formed in high stereoselectivity. It is 
hoped that these two reactions will allow easy access to Z-unsaturated esters and shorten 
the routes to biologically active molecules containing these precious motifs. 
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2.5 Experimental section 
 1H NMR spectra were measured using a Varian Unity Inova 400 MHz and 600 
MHz spectrometers. Chemical shifts are reported in ppm with the residual solvent 
resonance as the internal standard (CDCl3: 7.26 ppm). Data are reported as follows: 
chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br 
= broad, m = multiplet, app = apparent), coupling constants (Hz) and assignment. Proton-
decoupled 13C NMR spectra were recorded on Varian Unity Inova 400 (100 MHz) and 
600 (150 MHz) spectrometers. Chemical shifts are reported in ppm with the solvent 
resonance as the internal standard (CDCl3: 77.16 ppm). Infrared (IR) spectra were 
recorded on a Bruker FTIR Alpha (ATR Mode) spectrometer, λ in cm-1. Bands are 
characterized as broad (br), strong (s), medium (m), and weak (w). High-resolution mass 
spectrometry was performed on a Micromass LCT ESI-MS (positive mode) and a JEOL 
AccuTOF DART (positive mode) at the Boston College Mass Spectrometry Facility, 
Chestnut Hill, MA. 
 Chromatography was performed using flash chromatography on silica gel (SiO2, 
40-63 µm (230-400 mesh)) purchased from Silicycle. Visualization was performed using 
ultraviolet light (254 nm) as well as potassium permanganate (KMNO4). Melting points 
were obtained on a Thomas Hoover Capillary Melting point Apparatus of Arthur H. 
Thomas Company, Philadelphia, PA and are uncorrected.   
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Vacuum Pumps 
KNF Laboport N840.3FTP diaphragm vacuum pump connected to a Welch Labaid 
vacuum controller generates a vacuum of 100 torr at point of connection to the reaction 
vessel. 
 
Solvents 
Solvents were purged with argon and purified under a positive pressure of dry argon by a 
modified Innovative Technologies purification system: diethyl ether (Aldrich), and 
dichloromethane (Aldrich) were passed through activated alumina columns. Benzene 
(Aldrich) was passed successively through Cu and activated alumina columns. N-Pentane 
was allowed to stir over concentrated H2SO4 for three days and two washings with 
H2SO4, washed with H2O, followed by a saturated aqueous solution of NaHCO3, dried 
over MgSO4, and filtered. The resulting olefin-free n-pentane was then distilled over 
CaH2. Tetrahydrofuran (thf; Aldrich) was distilled from sodium benzophenone ketyl.    
 
Metal complex preparation 
Molybdenum bis-alkoxide 1 was prepared according to a known procedure.75 Ru carbene 
2 was purchased from Sigma-Aldrich. Ru carbenes 3 and 4 were purchased from Materia, 
Inc. Mo-monoaryloxide-monopyrrolide complexes 2.3,76 2.16,77 2.18,78 2.44,79 2.45,71 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
75 Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; Regan, M. J. Am. Chem. Soc. 
1990, 112, 3875−3886. 
76 Malcolmson, S. J.; Meek, S. J.; Sattely, E. S.; Schrock, R. R.; Hoveyda, A. H. Nature 2008, 456, 
933−937. 
77 Meek, S. J.; O’Brien, R. V.; Llaveria, J.; Schrock, R. R.; Hoveyda, A. H. Nature, 2011, 471, 461−466. 
78 Zhang, H.; Yu, E. C.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 
16493−16496. 
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2.4680 were prepared in situ according to previously reported procedures. The Mo and Ru 
complexes were handled in an inert N2-filled dry box.  
 
Reagents: All reagents were purchased from commercial vendors and used as received 
unless noted below. 
Allyl Benzene: Purchased from Aldrich and distilled over CaH2 prior to use. 
1-((allyloxy)methyl)-4-methoxybenzene: Prepared according to a known procedure.81 
Alumina (activated, basified): Purchased from Sigma Aldrich and used as received. 
Benzene-d6: Purchased from Cambridge Isotope Laboratories and distilled over sodium-
benzophenone ketal before use.   
Benzyl(hex-5-en-1-yl)sulfane: Prepared according to a known procedure with a minor 
modification using 6-bromo-1-hexene.82  
Benzyl Mercaptan: Purchased from Aldrich and used as received. 
8-bromo-1-octene: Purchased from Oakwood Chemicals and distilled over CaH2 prior to 
use. 
5-bromo-1-pentene: Purchased from Aldrich and used as received. 
Chloroform-d: Purchased from Cambridge Isotope Laboratories and used as received. 
Chlorotriethylsilane: Purchased from Aldrich and used as received. 
1-decene: Purchased from Aldrich and distilled over CaH2 prior to use.  
Geraniol: Purchased from Aldrich and used as received. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
79 Speed, A. W. H.; Mann, T. J.; O’Brien, R. V.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 
136, 16136−16139. 
80 Ibrahem, I.; Yu, M.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3844−3845. 
81 Harada, N-a.; Nishikata, T.; Nagashima, H. Tetrahedron 2012, 68, 3243−3252. 
82 Lin, Y. A.; Chalker, J. M.; Floyd, N.;Bernardes, G. J. L.; Davis, B. G. J. Am. Chem. Soc. 2008, 130, 
9642−9643. 
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Imidazole: Purchased from Oakwood and used as received. 
n-Butyllithium: Purchased from Strem as a 1.6 M solution in hexanes and used as 
received. 
7-Octen-1-ol: Purchased from TCI and used as received. 
2,4-Pentadienoic acid: Purchased from Aldrich and used as received. 
4-Penten-2-ol: Purchased from Alfa Aesar and used as received. 
Triethylamine: Purchased from Aldrich and distilled over CaH2 prior to use. 
Triisopropylsilyl Acetylene: Purchased from GFS chemicals and used as received. 
Trimethylacetyl Chloride: Purchased from Aldrich and used as received. 
Sodium Phenoxide: Purchased from Fischer and used as received. 
Sodium Sulfate (anhydrous): Purchased from Fischer and used as received. 
Vinylboronic acid pinacol ester: Purchased from Aldrich and purified by flash 
chromatography using 10% Et2O/pentane. It was then distilled over CaH2 prior to use. 
 
Olefin Metathesis Substrates: 
tert-Butyldimethyl(oct-7-en-1-yloxy)silane (S1): To a solution of 7-
Octen-1-ol (2.08 g, 16.2 mmol) in dichloromethane (54 mL) was added 
tert-Butyldimethylsilyl chloride (2.94 g, 19.5 mmol) followed by imidazole (1.33 g, 19.5 
mmol) and the mixture was allowed to stir for 12 hours. The reaction was then quenched 
by addition of 10% NaHCO3 and extracted with dichloromethane (3 x 30 mL). The 
combined organics were then washed with brine, dried over Na2SO4, filtered, and 
concentrated. The resulting oil was then purified by silica gel chromatography 
(hexanes/EtOAc, 100:0-98:2), which afforded the desired product as a clear, colorless oil 
OTBS
5
	   58	  
(3.70g, 15.3 mmol, 94% yield). The reagent was then dried by azeotropic distillation with 
benzene prior to its use in the olefin metathesis reaction. Spectral data are in agreement 
with the literature.83 
 
 
Dec-9-en-1-yn-1-yltriisopropylsilane (S2): Prepared according to a 
known procedure with minor modifications.84 To a flame-dried round 
bottom flask with a magnetic stir bar triisopropylacetylene (5.0 mL, 22.3 mmol) was 
added, followed by thf (25 mL). The solution was cooled to 4 °C and n-butyl lithium (1.6 
M in hexanes, 13.9 mL, 22.3 mmol) was added.  The reaction was allowed to warm to 22 
°C with stirring over the course of 1 h.  To the light yellow solution was added dropwise 
8-bromo-1-octene (1.9 mL, 11 mmol). The mixture was heated to reflux for 12 h then 
allowed to cool to 22 °C and the reaction was then quenched by the addition of H2O. The 
aqueous layer was then washed with dicholoromethane. The combined organics were 
washed with brine, dried over MgSO4 and concentrated under reduced pressure. The 
crude oil was distilled in a Kugelrohr apparatus (1 h, 100 °C, 0.75 torr) to afford yellow 
oil. The oil was then distilled from CaH2 under vacuum with heating and brought into the 
glove box to afford S2 as clear, colorless oil (658 mg, 2.25 mmol, 20% yield). IR (neat): 
2927 (br), 2863 (s), 2172 (m), 1462 (m), 994 (m), 909 (m), 882 (s), 771 (m), 675 (s), 659 
(s), 619 (br). 1H NMR (600 MHz, CDCl3): δ 5.81 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 4.99 
(ddt, J = 17.1, 2.3, 1.6 Hz, 1H), 4.93 (ddt, J = 10.2, 2.3, 1.2 Hz, 1H), 2.24 (t, J = 7.0 Hz, 
2H), 2.07 – 2.02 (m, 2H), 1.56 – 1.50 (m, 2H), 1.46 – 1.29 (m, 6H), 1.09 – 1.04 (m, 21H); 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
83 Brimble, M. A.; Flowers, C. L.; Hutchinson, J. K.; Robinson, J. E.; Sidford, M. Tetrahedron 2005, 61, 
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13C NMR (151 MHz, CDCl3): δ 139.3, 114.3, 109.4, 80.2, 33.9, 29.0, 28.9, 28.7, 28.7, 
20.0, 18.8, 11.5; HRMS (DART) [M+H]+ calcd for C19H37Si: 293.2664, found: 
293.2678. 
 
 (E)-3,7-Dimethyl-1-(pent-4-en-1-yloxy)octa-2,6-
diene (S3): In an N2-filled dry box dry sodium hydride (324 mg, 13.5 mmol 2.0 equiv.) 
was weighed into an oven-dried flask with a magnetic stirbar. The flask was then sealed 
and brought out of the dry box then dimethylformamide was then added (11 mL) and the 
mixture was allowed to stir under N2 at 4° C.  A cooled solution of geraniol (2.08 g, 13.5 
mmol 2.0 equiv) in dmf (4 mL) was added by cannula and the resulting mixture was then 
allowed to warm to room temperature and to stir under N2 for one hour at which time 5-
bromo-1-pentene (0.800 mL, 6.75 mmol) was then added and the mixture was warmed to 
60 °C with stirring for 12 h, at which point the reaction was quenched by addition of 
H2O. The aqueous layer was washed with three 30 mL portions of Et2O. The combined 
organic layers were then washed once with brine and dried over MgSO4, filtered, and 
concentrated in vacuo. The resulting yellow oil was purified by silica gel chromatography 
(Pentane:Et2O, 100:0-99:1) which afforded the title compound as pale yellow oil (675 
mg, 3.03 mmol, 45% yield). The reagent was then further purified by distillation over 
CaH2 prior to its use in the olefin metathesis reaction. IR (neat): 2967 (m), 2917 (m), 
2853 (m), 1641 (w), 1443 (m), 1376 (m), 1104 (s), 1040 (w), 991 (m), 910 (s); 1H NMR 
(600 MHz, CDCl): δ 5.81 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 5.35 (ddq, J = 6.7, 5.4, 1.3 
Hz, 1H), 5.09 (dddd, J = 7.0, 5.6, 2.8, 1.4 Hz, 1H), 5.02 (ddt, J = 17.1, 1.7 Hz, 1H), 4.95 
(ddt, J = 10.2, 2.1, 1.2 Hz, 1H), 3.97 (ddq, J = 6.7, 5.3, 0.8 Hz, 2H), 3.41 (t, J = 6.6 Hz, 
O
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2H), 2.15 – 2.01 (m, 8H), 1.71 – 1.64 (m, 10H), 1.61 – 1.58 (m, 3H); 13C NMR (151 
MHz, CDCl3): δ 140.0, 138.5, 131.7, 124.2, 121.2, 114.8, 69.6, 67.4, 39.7, 30.5, 29.1, 
26.5, 25.8, 17.8, 16.6; HRMS (DART) [M+H]+ calcd for C15H27O: 223.2062, found: 
223.2062. 
 
Triethyl(pent-4-en-2-yloxy)silane (S4): Into a flask was added a stir bar, 
4-penten-2-ol (711 mg, 8.30 mmol), and dichloromethane, (28 mL). Chlorotriethylsilane 
(1.70 mL, 9.90 mL) was then added followed by imidazole (674 mg, 9.90 mmol) and the 
reaction mixture was allowed to stir at 22º C for 12 h under an atmosphere of nitrogen. 
The reaction was then quenched by addition of H2O and the aqueous layer was washed 
with three 30 mL portions of dichloromethane. The combined organic layers were then 
washed once with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The 
resulting oil was then purified by chromatography on basic alumina using hexanes, which 
afforded the title compound as colorless oil (976 mg, 60% yield). The oil was then 
distilled over CaH2 prior to use in the olefin metathesis reaction. IR (neat): 2954 (s), 
2938 (w), 2911 (m), 2876 (s), 1414 (w), 1237 (m), 1128 (m), 1128 (br), 1003 (s), 739 (s); 
1H NMR (400 MHz, CDCl3-d): δ 5.81 (ddt, J = 17.3, 10.2, 7.2 Hz, 1H), 5.09 – 5.00 (m, 
2H), 3.84 (septet, J = 6.1 Hz, 1H), 2.30 – 2.11 (m, 2H), 1.14 (d, J = 6.1 Hz, 3H), 0.96 (t, J 
= 7.9 Hz, 9H), 0.59 (q, J = 7.9 Hz, 6H); 13C NMR (151 MHz, CDCl3): δ 135.7, 116.7, 
68.4, 44.5, 23.6, 7.0, 5.1; HRMS (DART) [M+H]+ calcd for C11H25OSi: 201.1675, 
found: 201.1677. 
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Phenyl-(E)-penta-2,4-dienoate (2.35): To a flask containing 2,4-
pentadienoic acid (824 mg, 8.40 mmol) was added thf (53 mL). The flask was placed 
under an N2 atmosphere and then cooled to -78 °C. Trimethylacetyl chloride (1.03 mL, 
8.40 mmol) followed by triethylamine (1.29 mL, 9.24 mmol) were then added and the 
mixture was stirred at -78 °C for 15 minutes, then allowed to warm to room temperature 
with stirring over 45 minutes. A -78º C solution of sodium phenoxide (1.07g, 9.24mmol) 
in tetrahydrofuran (20 mL) was then transferred by cannula into this mixture. The 
resulting mixture was then allowed to warm to room temperature, with stirring, for 12 h. 
The reaction was then quenched by the addition of 2 M KHSO4 in H2O. The aqueous 
layer was washed with three 30 mL portions of EtOAc and the combined organic layers 
were washed once with brine, dried over MgSO4, filtered, and concentrated in vacuo. The 
resulting brown oil was then purified by silica gel chromatography (hexanes:Et2O 100:0-
99:1) to afford the title compound as a colorless oil (1.0 g, 5.74 mmol, 68% yield). IR 
(neat): 3043 (w), 1728 (s), 1638 (m), 1589 (m), 1487 (m), 1415 (w), 1304 (m), 1186 (s), 
1120 (s), 1006 (s); 1H NMR (600 MHz, CDCl3) δ 7.45 (ddt, J = 15.4, 11.0, 0.8 Hz, 1H), 
7.41 – 7.37 (m, 2H), 7.25 – 7.22 (m, 1H), 7.14 – 7.12 (m, 2H), 6.55 (dddd, J = 17.0, 11.0, 
10.1, 0.8 Hz, 1H), 6.11 (br d, J = 15.4 Hz, 1H), 5.70 (apparent d, J = 17.0 Hz, 1H), 5.58 
(apparent d, J = 10.1 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 165.3, 150.9, 146.7, 
134.7, 129.5, 126.8, 125.9, 121.7, 121.4; HRMS (DART) [M+H]+ calcd for C11H11O2: 
175.0759, found: 175.0765. 
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Table 2.3. Catalytic CM with 1-Decene and Phenyl Dienoate with "Traditional" Mo Alkylidenes and Ru Carbenes
N
Mo
O
O
Me
Me
Ph
i-Pr i-Pr
CF3F3C
F3C
CF3
Ru
Oi-Pr
NMesMesN
Cl
Cl
Ph Ru
NMesMesN
Cl
Cl
PCy3
N N
Ru
O
i-PrO
O
NO
i-Pr
i-Pr
1 2 3 4
PhO
O
(3 equiv)
5 mol % Mo or Ru complex
PhO
O
Me
6
6
Me
solvent 0.1 M, 22 °C, 100 torr
SolventEntry conv (%) Z:Eb
3 19 13:87
2 95 8:92
1 C6H6 <5 N/D
yield (%)
C6H6
C6H6
Complex
1
2
3
4 <5 N/Dthf (ambient) 4
N/D
87%*
N/D
N/D
* Isolated as a mixture of the internal olefin cross partner and the desired product
a Reactions performed under N2 atm. b Determined by analysis of 1H NMR spectra of unpurified mixtures and 
refer to consumption of the limiting substrate (2.35) (±2%).
2.35 2.20
+
2.36
Catalytic Cross-Metathesis with “Traditional” Complexes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General Procedure: Cross-Metathesis with Phenyl Dienoate 2.35 
In an N2-filled dry box, an oven-dried 8 mL vial equipped with a magnetic stir bar was 
charged with phenyl dienoate (1 equiv). To this oil was then added 3 equiv of neat 
terminal cross-partner. A septum containing a needle was then placed on the vial. A 
solution of complex 2.45 or 2.18 (0.1 M in benzene) was then added to the vial, which 
was quickly connected to a 100-torr vacuum generated from a diaphragm vacuum pump. 
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The resulting solution was allowed to stir for 15 minutes, at which time the reaction was 
taken from the dry box and quenched by exposure to air and addition of wet perdeutero-
benzene. The percent conversion and Z:E ratio of the resulting mixture was determined 
by 1H NMR analysis. Purification of the mixture by silica gel chromatography provided 
the target dienoate. 
 
 
Phenyl (2E,4Z)-trideca-2,4-dienoate (2.36) 
Following the general procedure, to a vial containing phenyl 
dienoate 2.35 (13.5 mg, 0.0774 mmol), 1-decene (32.6 mg, 0.232 mmol, 3 equiv) was 
added followed by a solution of 2.45 (38 µL, 0.0038 mmol, 0.05 equiv). The mixture was 
allowed to stir under a vacuum of 100 torr for 15 minutes; To the resulting mixture was 
added 250 µL of tetrahydrofuran, followed by a 1 M solution of tetra-n-butylammonium 
fluoride (8 µL 0.007 mmol, 0.1 equiv.).  The resulting mixture was allowed to stir for 10 
minutes then diluted with hexanes and filtered through a pad of Celite. The resulting pale 
brown oil was then purified by silica gel chromatography (hexanes:Et2O, 100:0-99:1) 
which afforded the title compound as colorless oil (18.6 mg, 0.0649 mmol, 84% yield, 
96:4 Z:E). IR (neat): 2923 (s), 2853 (m), 1730 (s), 1633 (m), 1592 (w), 1492 (m), 1457 
(w), 1411 (w), 1194 (s), 1071 (s); 1H NMR (600 MHz, CDCl3), Z isomer: δ 7.79 (ddd, J 
= 15.3, 11.7, 1.1 Hz, 1H), 7.41 – 7.37 (m, 2H), 7.25 – 7.22 (m, 1H), 7.15 – 7.12 (m, 2H), 
6.25 – 6.17 (m, 1H), 6.06 (d, J = 15.3, 1H), 5.95 (dtt, J = 9.7, 7.8, 1.1, 1H), 2.34 (m, 2H), 
[diagnostic signal for the E isomer: 1.48 – 1.41 (m, 2H), 1.35 – 1.24 (m, 10H), 0.91 – 
0.86 (m, 3H); 13C NMR (151 MHz, CDCl3): δ 165.8, 151.0, 143.1, 141.6, 129.5, 126.5, 
PhO
O
Me
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125.8, 121.8, 120.3, 32.0, 29.6, 29.5, 29.4, 29.4, 28.6, 22.8, 14.2; HRMS (DART) 
[M+H]+ calcd for C19H27O2: 287.2011, found: 287.2025.  
 
Phenyl (2E,4Z)-11-bromoundeca-2,4-dienoate (2.37) 
Following the general procedure, to a vial containing phenyl 
dienoate 2.35 (11.4 mg, 0.0774 mmol), 8-bromo-1-octene (37.5 mg, 0.196 mmol, 3 
equiv) was added followed by a solution of 2.45 (32 µL, 0.0032 mmol, 0.05 equiv). The 
mixture was allowed to stir under a vacuum of 100 torr for 15 minutes; purification of the 
resulting residue by silica gel chromatography (hexanes:Et2O, 100:0-98:2) which 
afforded the title compound as colorless oil (19.3 mg, 0.0572 mmol, 87% yield, 94:6 
Z:E). IR (neat): 2929 (m), 2855 (m), 1728 (s), 1633 (m), 1591 (w), 1492 (m), 1456 (w), 
1259 (br), 1195 (s), 1128 (s), 1128 (s); 1H NMR (400 MHz, CDCl3), Z isomer: δ 7.78 
(ddd, J = 15.2, 11.7, 0.9 Hz, 1H), 7.42 – 7.36 (m, 2H), 7.26 – 7.21 (m, 1H), 7.16 – 7.11 
(m, 2H), 6.22 (m, 1H), 6.07 (d, J = 15.2, 1H), 5.93 (m, 1H), 3.41 (t, J = 6.8 Hz, 2H), 2.35 
(qd, J = 7.3, 1.5 Hz, 2H), [diagnostic signal for the E isomer: 2.22 (qd, J = 6.8 Hz)], 1.92 
– 1.81 (m, 2H), 1.52 – 1.32 (m, 6H); 13C NMR (101 MHz, CDCl3): δ 165.8, 150.9, 
142.6, 141.4, 129.5, 126.7, 125.8, 121.8, 120.5, 34.0, 32.8, 29.3, 28.5, 28.4, 28.1; HRMS 
(DART) [M+H]+ calcd for C17 H22O2Br: 337.0803, found: 337.0813.  
 
 
 
 
 
 
PhO
O
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 Phenyl (2E,4Z)-11-((tert-butyldimethylsilyl)oxy)undeca-
2,4-dienoate (2.38) 
Following the general procedure, to a vial containing phenyl dienoate 2.35 (14.7 mg, 
0.0843 mmol), octenyl-OTBS S1 (61.3 mg, 0.253 mmol, 3 equiv) was added followed by 
a solution of 2.45 (42 µL, 0.0042 mmol, 0.05 equiv).  The mixture was allowed to stir 
under a vacuum of 100 torr for 15 minutes; purification of the resulting residue by silica 
gel chromatography (hexanes:Et2O, 100:0-98:2) afforded the title compound as colorless 
oil (27.8 mg, 0.0715 mmol, 85% yield, 96:4 Z:E). IR (neat): 2928 (m), 2855 (m), 1730 
(s), 1633 (m), 1592 (m), 1492 (m), 1252 (br), 1194 (s), 1120 (s), 1098 (br); 1H NMR 
(400 MHz, CDCl3), Z isomer: δ 7.79 (ddd, J = 15.2, 11.7, 0.9 Hz, 1H), 7.42 – 7.36 (m, 
2H), 7.26 – 7.21 (m, 1H), 7.15 – 7.12 (m, 2H), 6.21 (m, 1H), 6.06 (d, J = 15.2 Hz, 1H), 
5.95 (m, 1H), 3.60 (t, J = 6.6 Hz, 2H), 2.39 – 2.29 (m, 2H), [diagnostic signal for the E 
isomer: 2.21 (qd, J = 6.9 Hz)], 1.57 – 1.29 (m, 8H), 0.89 (s, 9H), 0.05 (s, 6H); 13C NMR 
(101 MHz, CDCl3): δ 165.8, 151.0, 143.0, 141.5, 129.5, 126.5, 125.8, 121.8, 120.4, 63.3, 
32.9, 29.5, 29.2, 28.5, 26.1, 25.8, 18.5, -5.1; HRMS (DART) [M+H]+ calcd for 
C23H37O3Si: 389.2512, found: 389.2509. 
 
 
 
 
 
 
 
PhO
O
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Phenyl (2E,4Z)-9-(benzylthio)nona-2,4-dienoate (2.47) 
Following the general procedure, to a vial containing phenyl 
dienoate 2.35 (13.4 mg, 0.0769 mmol), benzyl(hex-5-en-1-yl)sulfane (47.6 mg, 0.231 
mmol, 3 equiv) was added followed by a solution of 2.45 (38 µL, 0.0038 mmol, 0.05 
equiv). The mixture was allowed to stir under a vacuum of 100 torr for 15 minutes; 
purification of the resulting residue by silica gel chromatography (hexanes:Et2O, 100:0-
95:5) afforded the title compound as colorless oil (18.5 mg, 0.0524 mmol, 68% yield, 
98:2 Z:E). IR (neat): 2922 (m), 1725 (s), 1631 (s), 1591 (m), 1491 (s), 1453 (m), 1239 
(br), 1192 (s), 1128 (s), 995 (w), 961 (m), 699 (br), 565 (w), 499 (w); 1H NMR (400 
MHz, CDCl3): δ 7.76 (ddd, J = 15.2, 11.7, 0.9 Hz, 1H), 7.44 – 7.37 (m, 2H), 7.31 (d, J = 
4.3 Hz, 4H), 7.28 – 7.21 (m, 2H), 7.17 – 7.11 (m, 2H), 6.27 – 6.17 (m, 1H), 6.07 (d, J = 
15.3 Hz, 1H), 5.95 – 5.85 (m, 1H), 3.71 (s, 2H), 2.43 (t, J = 7.1 Hz, 2H), 2.32 (qd, J = 
7.4, 1.5 Hz, 2H), 1.68 – 1.46 (m, 6H); 13C NMR (151 MHz, CDCl3): δ 165.7, 150.9, 
142.2, 141.3, 138.7, 129.5, 129.0, 128.6, 127.1, 126.8, 125.8, 121.8, 120.7, 36.5, 31.3, 
28.8, 28.6, 28.1; HRMS (DART) [M+H]+ calcd for C22H25O2S: 353.1575, found: 
353.1589. 
 
 
Phenyl (2E,4Z)-13-(triisopropylsilyl)trideca-2,4-dien-
12-ynoate (2.39) 
Following the general procedure, to a vial containing phenyl dienoate 2.35 (12.8 mg, 
0.0734 mmol), dec-9-en-1-yn-1-yltriisopropylsilane S2 (64.4 mg, 0.220 mmol, 3 equiv) 
was added followed by a solution of 2.45 (36 µL, 0.0036 mmol, 0.05 equiv).  The 
PhO
O
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mixture was allowed to stir under a vacuum of 100 torr for 15 minutes; purification of the 
resulting residue by silica gel chromatography (hexanes:Et2O, 100:0-99.5:0.5) afforded 
the title compound as colorless oil (26.3 mg, 0.0599 mmol, 82% yield, 98:2 Z:E). IR 
(neat): 2926 (m), 2862 (s), 2169 (w), 1731 (s), 1633 (m), 1592 (w), 1461 (m), 1411 (m), 
1194 (s), 659 (m); 1H NMR (600 MHz, CDCl3): δ 7.78 (ddd, J = 15.2, 11.7, 0.9 Hz, 
1H), 7.42 – 7.37 (m, 2H), 7.26 – 7.21 (m, 1H), 7.16 – 7.11 (m, 2H), 6.21 (ddtd, J = 11.7, 
10.7, 1.5, 0.9 Hz, 1H), 6.07 (d, J = 15.2, 1H), 5.94 (dtt, J = 10.7, 7.8, 0.9 Hz, 1H), 2.34 
(qd, J = 7.8, 1.5 Hz, 2H), 2.25 (t, J = 6.9 Hz, 2H), 1.59 – 1.33 (m, 8H), 1.06−1.08 (m, 
21H); 13C NMR (151 MHz, CDCl3): δ 165.8, 151.0, 142.9, 141.5, 129.5, 126.6, 125.8, 
121.8, 120.4, 109.2, 80.3, 29.4, 28.9, 28.8, 28.7, 28.5, 19.9, 18.8, 11.5; HRMS (ESI) 
[M+H]+ calcd for C28H43O2Si: 439.3032, found: 439.3034. 
 
 
Phenyl (2E,4Z)-8-(((E)-3,7-dimethylocta-2,6-
dien-1-yl)oxy)octa-2,4-dienoate (2.48) 
Following the general procedure, to a vial 
containing phenyl dienoate 2.35 (14.0 mg, 0.0803 mmol), (E)-3,7-dimethyl-1-(pent-4-en-
1-yloxy)octa-2,6-diene S3 (53.1 mg, 0.240 mmol, 3 equiv) was added followed by a 
solution of 2.45 (40 µL, 0.0040 mmol, 0.05 equiv). The mixture was allowed to stir under 
a vacuum of 100 torr for 15 minutes; purification of the resulting residue by silica gel 
chromatography (hexanes:Et2O, 100:0-95:5) afforded the title compound as colorless oil 
(13.1 mg, 0.0355 mmol, 44% yield, 98:2 Z:E). IR (neat): 2919 (m), 2853 (m), 1729 (s), 
1633 (m), 1592 (w), 1492 (m), 1454 (w), 1194 (s), 1117 (s), 499 (w); 1H NMR (600 
MHz, CDCl3): δ 7.80 (ddd, J = 15.2, 11.6, 1.1 Hz, 1H), 7.41 – 7.36 (m, 2H), 7.26 – 7.21 
PhO
O
O
3
	   68	  
PhO
O
OTES
Me
(m, 1H), 7.15 – 7.11 (m, 2H), 6.26 – 6.20 (m, 1H), 6.07 (d, J = 15.2 Hz, 1H), 5.95 (dt, J = 
10.7, 7.9 Hz, 1H), 5.35 (m, 1H), 5.08 (m, 1H), 3.98 (d, J = 6.7 Hz, 2H), 3.44 (t, J = 6.4 
Hz, 2H), 2.47 – 2.41 (m, 2H), 2.13 – 2.06 (m, 2H), 2.02 (dd, J = 9.3, 6.1 Hz, 2H), 1.78 – 
1.70 (m, 2H), 1.70 – 1.65 (m, 6H), 1.59 (s, 3H); 13C NMR (151 MHz, CDCl3): δ 165.7, 
151.0, 142.1, 141.4, 140.2, 131.7, 129.5, 127.0, 125.8, 124.2, 121.8, 121.0, 120.7, 69.2, 
67.5, 39.7, 29.5, 26.5, 25.8, 25.3, 17.8, 16.6; HRMS (DART) [M+NH4]+ calcd for 
C24H36NO3: 386.2695, found: 386.2694. 
 
Phenyl (2E,4Z)-7-((triethylsilyl)oxy)octa-2,4-dienoate 
(2.40) 
Following the general procedure, to a vial containing phenyl dienoate 2.35 (13.3 mg, 
0.0763 mmol), triethyl(pent-4-en-2-yloxy)silane S4 (45.9 mg, 0.229 mmol, 3 equiv) was 
added followed by a solution of 2.45 (38 µL, 0.0038 mmol, 0.05 equiv). The mixture was 
allowed to stir under a vacuum of 100 torr for 15 minutes; purification of the resulting 
residue by silica gel chromatography (hexanes:Et2O, 100:0-97:3) afforded the title 
compound as colorless oil (13.3 mg, 0.0383 mmol, 50% yield, 96:4 Z:E). IR (neat): 2954 
(m), 2875 (m), 1730 (s), 1634 (m), 1592 (m), 1492 (m), 1194 (s), 1117 (s), 1002 (s), 720 
(br); 1H NMR (400 MHz, CDCl3), Z isomer: δ 7.77 (ddd, J = 15.3, 11.6, 1.1 Hz, 1H), 
7.43 – 7.35 (m, 2H), 7.26 – 7.20 (m, 1H), 7.16 – 7.10 (m, 2H), 6.35 – 6.26 (m, 1H), 6.07 
(m, 1H), 6.04 – 5.97 (m, 1H), 3.94 (sextet, J = 6.0 Hz, 1H), 2.48 (m, 2H), [diagnostic 
signal for the E isomer: 2.38 – 2.31 (m)], 1.18 (d, J = 6.0 Hz, 3H), 1.00 – 0.93 (m, 9H), 
0.65 – 0.56 (m, 6H); 13C NMR (151 MHz, CDCl3): δ 165.9, 151.0, 141.6, 139.0, 129.5, 
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128.1, 125.8, 121.8, 120.8, 68.0, 38.5, 23.9, 7.0, 5.1; HRMS (ESI) [M+H]+ calcd for 
C20H31O3Si: 347.2043, found: 347.2035. 
 
 
Phenyl (2E,4Z)-6-phenylhexa-2,4-dienoate (2.42) 
Following the general procedure, to a vial containing phenyl dienoate 2.35 (13.4 mg, 
0.0769 mmol), allyl benzene (27.3 mg, 0.231 mmol, 3 equiv) was added followed by a 
solution of 2.18 (23 µL, 0.0023 mmol, 0.03 equiv). The mixture was allowed to stir under 
a vacuum of 100 torr for 15 minutes; purification of the resulting residue by silica gel 
chromatography (hexanes:Et2O, 100:0-99:1) afforded the title compound contaminated 
with 2% by weight of the phenol ligand as colorless oil (9.7 mg, 0.036 mmol, 48% yield, 
90:10 Z:E). IR (neat): 3027 (w), 2920 (w), 1725 (s), 1632 (m), 1590 (m), 1454 (w), 1408 
(w), 1244 (m), 1192 (s), 1142 (s), 1108 (s); 1H NMR (600 MHz, CDCl3), Z isomer: δ 
7.92 (ddd, J = 15.2, 11.7, 1.3 Hz, 1H), 7.42 – 7.38 (m, 2H), 7.34 – 7.30 (m, 2H), 7.26 – 
7.23 (m, 2H), 7.22 – 7.19 (m, 2H), 7.16 – 7.14 (m, 2H), 6.34 (m, 1H), 6.16 (d, J = 15.2 
Hz, 1H), 6.09 (dtt, J = 9.9, 7.9, 0.9 Hz, 1H), 3.70 (d, 2H), [diagnostic signal for the E 
isomer: 3.55 (d)]; 13C NMR (101 MHz, CDCl3): δ 165.6, 150.9, 140.9, 140.2, 139.2, 
129.5, 128.8, 128.6, 127.1, 126.6, 125.9, 121.8, 121.6, 34.6. HRMS (ESI) [M+H]+ calcd 
for C18H17O2: 265.1228, found: 265.1238. 
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Phenyl (2E,4Z)-6-((4-methoxybenzyl)oxy)hexa-2,4-
dienoate (2.43) 
Following the general procedure, to a vial containing phenyl dienoate 2.35 (13.1 mg, 
0.0752 mmol), 1-((allyloxy)methyl)-4-methoxybenzene (40.2 mg, 0.226 mmol, 3 equiv) 
was added followed by a solution of 2.18 (22 µL, 0.0022 mmol, 0.03 equiv).  The 
mixture was allowed to stir under a vacuum of 100 torr for 15 minutes; purification of the 
resulting residue by silica gel chromatography (hexanes:Et2O, 100:0-96:4) afforded the 
title compound as yellow oil (11.7 mg, 0.0360 mmol, 48% yield, 94:6 Z:E). IR (neat): 
2922 (m), 1725 (s), 1611 (m), 1511 (s), 1491 (m), 1244 (s), 1192 (s), 1155 (s), 1116 (s), 
817 (s); 1H NMR (600 MHz, CDCl3), Z isomer: δ 7.74 (ddd, J = 15.3, 11.7, 0.9 Hz, 
1H), 7.43 – 7.38 (m, 2H), 7.31 – 7.26 (m, 2H), 7.24 (ddt, J = 7.8, 7.1, 1.2 Hz, 1H), 7.14 – 
7.12 (m, 2H), 6.89 – 6.85 (m, 2H), 6.32 (m, 1H), 6.11 (d, J = 15.3 Hz, 1H), 6.05 (m, 1H), 
4.49 (s, 2H), 4.29 (dd, J=6.5, 1.6 Hz, 2H), [diagnostic signal for the E isomer: 4.14 (dd, J 
= 5.3, 1.6 Hz)], 3.78 (s, 3H); 13C NMR (151 MHz, CDCl3): δ 165.3, 159.5, 150.9, 140.7, 
137.4, 130.0, 129.7, 129.6, 128.4, 125.9, 122.3, 121.7, 114.0, 72.6, 65.9, 55.4; HRMS 
(DART) [M+NH4]+ calcd for C20H24NO4: 342.1705, found: 342.1719. 
 
Phenyl (2E,4Z)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)penta-2,4-dienoate (2.41) 
In an N2-filled dry box an oven-dried 8 mL vial equipped with a magnetic stir bar was 
charged with phenyl dienoate 2.35 (12.7 mg, 0.0729 mmol), vinylboronic acid pinacol 
ester (56.1 mg, 0.365 mmol, 5 equiv) was added followed by a solution of 2.18 (21 µL, 
PhO
O
OPMB
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0.0021 mmol, 0.03 equiv).  The vial was then sealed and allowed to stir for 18 hours.  
The reaction vial was removed from the dry box and exposed to air, then concentrated in 
vacuo and the mixture was purified by silica gel chromatography (hexanes:EtOAc, 100:0-
96:4) which afforded the title compound as a colorless solid (16.8 mg, 0.0559 mmol, 77% 
yield). IR (neat): 2922 (m), 1724 (s), 1632 (m), 1583 (s), 1382 (m), 1341 (s), 1259 (s), 
1135 (s), 963 (s), 492 (w); 1H NMR (600 MHz, CDCl3): δ 8.24 (ddd, J = 15.4, 11.5, 0.8 
Hz, 1H), 7.42 – 7.37 (m, 2H), 7.25 – 7.22 (m, 1H), 7.16 – 7.13 (m, 2H), 7.03 – 6.97 (m, 
1H), 6.17 (dt, J = 15.4, 0.8 Hz, 1H), 5.90 (dt, J = 13.3, 0.8 Hz, 1H), 1.30 (s, 12H); 13C 
NMR (101 MHz, CDCl3): δ 165.5, 151.0, 146.5, 145.7, 129.5, 125.8, 124.0, 121.7, 83.9, 
25.0; HRMS (DART) [M+H]+ calcd for C17H22BO4: 301.1611, found: 301.1612; 
Melting point: 141 °C (decomp.). 
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